{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:26Z","timestamp":1793908646638,"version":"4.8.0"},"reference-count":370,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00210-025-04069-z","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:57:16Z","timestamp":1744192636000},"page":"11541-11579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The current findings on the gut-liver axis and the molecular basis of NAFLD\/NASH associated with gut microbiome dysbiosis"],"prefix":"10.1007","volume":"398","author":[{"given":"Seema","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampat Singh","family":"Tanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"1","key":"4069_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.33696\/Pharmacol.6.052","volume":"6","author":"TA Addissouky","year":"2024","unstructured":"Addissouky TA, El Sayed IET, Ali MM, Alubiady MHS, Wang Y (2024) Schisandra chinensis in liver disease: Exploring the mechanisms and therapeutic promise of an ancient Chinese botanical. Arch Pharmacol Ther 6(1):27\u201333","journal-title":"Arch Pharmacol Ther"},{"key":"4069_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.015","volume":"44","author":"R Afrin","year":"2017","unstructured":"Afrin R, Arumugam S, Rahman A, Wahed MI, Karuppagounder V, Harima M, Suzuki H, Miyashita S, Suzuki K, Yoneyama H, Ueno K, Watanabe K (2017) Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-\u03baB translocation. Int Immunopharmacol 44:174\u2013182. https:\/\/doi.org\/10.1016\/j.intimp.2017.01.015","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4069_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"key":"4069_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW (2021) Adipose tissue and insulin resistance in obese. Biomed Pharmacother 137:111315. https:\/\/doi.org\/10.1016\/j.biopha.2021.111315","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"4069_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","volume":"63","author":"F Ameer","year":"2014","unstructured":"Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N (2014) De novo lipogenesis in health and disease. Metabolism 63(7):895\u2013902. https:\/\/doi.org\/10.1016\/j.metabol.2014.04.003","journal-title":"Metabolism"},{"key":"4069_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1472-6882-13-160","volume":"13","author":"ZA Amin","year":"2013","unstructured":"Amin ZA et al (2013) Gene expression profiling reveals underlying molecular mechanism of hepatoprotective effect of Phyllanthus niruri on thioacetamide-induced hepatotoxicity in Sprague Dawley rats. BMC Complement Altern Med 13:160","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"4069_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/15376510903039060","volume":"19","author":"T Anand","year":"2009","unstructured":"Anand T, Vijayaraghavan R, Bansal I, Bhattacharya BK (2009) Role of inflammatory cytokines and DNA damage repair proteins in sulfur mustard exposed mice liver. Toxicol Mech Methods 19(5):356\u2013362. https:\/\/doi.org\/10.3109\/15376510903039060","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"4069_CR8","first-page":"1","volume":"81","author":"AK Anderson","year":"2020","unstructured":"Anderson AK (2020) Regulation of Murine Physiology and Metabolism by the Adipocyte Circadian Clock through Sphingosine Kinase 1. Dissert Abstracts Int Sect B Sci Eng 81(1):1","journal-title":"Dissert Abstracts Int Sect B Sci Eng"},{"key":"4069_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.105922","volume":"89","author":"QM Anstee","year":"2020","unstructured":"Anstee QM, Neuschwander-Tetri BA, Wong VWS, Abdelmalek MF, Younossi ZM, Yuan J, Sanyal A (2020) Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. Contemp Clin Trials 89:105922. https:\/\/doi.org\/10.1016\/j.cct.2019.105922","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"4069_CR10","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/nu12082340","volume":"12","author":"N Arias","year":"2020","unstructured":"Arias N, Arboleya S, Allison J, Kaliszewska A, Higarza SG, Gueimonde M, Arias JL (2020) The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases. Nutrients 12(8):2340. https:\/\/doi.org\/10.3390\/nu12082340","journal-title":"Nutrients"},{"key":"4069_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29968","volume":"6","author":"AP Arruda","year":"2017","unstructured":"Arruda AP, Pers BM, Parlakgul G, G\u00fcney E, Goh T, Cagampan E, Hotamisligil GS (2017) Defective STIM-mediated store operated Ca2+ entry in hepatocytes leads to metabolic dysfunction in obesity. Elife 6:e29968. https:\/\/doi.org\/10.7554\/eLife.29968","journal-title":"Elife"},{"issue":"7","key":"4069_CR12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","volume":"158","author":"V Azzu","year":"2020","unstructured":"Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A (2020) Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology 158(7):1899\u20131912. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.054","journal-title":"Gastroenterology"},{"key":"4069_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.102174","volume":"47","author":"S Bandyopadhyay","year":"2023","unstructured":"Bandyopadhyay S, Samajdar SS, Das S (2023) Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 47:102174. https:\/\/doi.org\/10.1016\/j.clinre.2022.102174","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"4069_CR14","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, Savastano S (2018) Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients 10(12):1971. https:\/\/doi.org\/10.3390\/nu10121971","journal-title":"Nutrients"},{"issue":"12","key":"4069_CR15","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.3390\/ijms24129996","volume":"24","author":"A Basha","year":"2023","unstructured":"Basha A, May SC, Anderson RM, Samala N, Mirmira RG (2023) Non-alcoholic fatty liver disease: translating disease mechanisms into therapeutics using animal models. Int J Mol Sci 24(12):9996. https:\/\/doi.org\/10.3390\/ijms24129996","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4069_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40842-024-00190-0","volume":"10","author":"B Basil","year":"2024","unstructured":"Basil B, Myke-Mbata BK, Eze OE, Akubue AU (2024) From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome\u2013current insights and future directions. Clin Diab Endocrinol 10(1):39. https:\/\/doi.org\/10.1186\/s40842-024-00190-0","journal-title":"Clin Diab Endocrinol"},{"issue":"1","key":"4069_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4239\/wjd.v13.i1.65","volume":"13","author":"RM Bastos","year":"2022","unstructured":"Bastos RM, Rangel \u00c9B (2022) Gut microbiota-derived metabolites are novel targets for improving insulin resistance. World J Diabetes 13(1):65\u201380. https:\/\/doi.org\/10.4239\/wjd.v13.i1.65","journal-title":"World J Diabetes"},{"issue":"3","key":"4069_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cmet.2018.01.005","volume":"27","author":"PV Bauer","year":"2018","unstructured":"Bauer PV, Duca FA, Waise TZ, Dranse HJ, Rasmussen BA, Puri A, Lam TK (2018) Lactobacillus gasseri in the upper small intestine impacts an ACSL3-dependent fatty acid-sensing pathway regulating whole-body glucose homeostasis. Cell Metab 27(3):572\u2013587. https:\/\/doi.org\/10.1016\/j.cmet.2018.01.005","journal-title":"Cell Metab"},{"issue":"1","key":"4069_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20429-4","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Zekry A (2021) Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun 12(1):187. https:\/\/doi.org\/10.1038\/s41467-020-20429-4","journal-title":"Nat Commun"},{"issue":"5","key":"4069_CR20","doi-asserted-by":"publisher","first-page":"BE01","DOI":"10.7860\/JCDR\/2022\/55523.16393","volume":"16","author":"N Berakdar","year":"2022","unstructured":"Berakdar N, Alahmad A (2022) Review of oxidative stress and antioxidative. J Clin Diagn Res 16(5):BE01\u2013BE06. https:\/\/doi.org\/10.7860\/JCDR\/2022\/55523.16393","journal-title":"J Clin Diagn Res"},{"key":"4069_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2022.100555","volume":"27","author":"M Bilen","year":"2022","unstructured":"Bilen M, Benhammouda S, Slack RS, Germain M (2022) The integrated stress response as a key pathway downstream of mitochondrial dysfunction. Curr Opin Physio 27:100555. https:\/\/doi.org\/10.1016\/j.cophys.2022.100555","journal-title":"Curr Opin Physio"},{"key":"4069_CR22","doi-asserted-by":"publisher","first-page":"114346","DOI":"10.1016\/j.bcp.2020.114346","volume":"184","author":"KW Bock","year":"2021","unstructured":"Bock KW (2021) Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation. Biochem Pharmacol 184:114346. https:\/\/doi.org\/10.1016\/j.bcp.2020.114346","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4069_CR23","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/carcin\/bgu073","volume":"35","author":"MG Borland","year":"2014","unstructured":"Borland MG, Krishnan P, Lee C, Albrecht PP, Shan W, Bility MT, Peters JM (2014) Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor \u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) in keratinocytes. Carcinogenesis 35(7):1602\u20131612. https:\/\/doi.org\/10.1093\/carcin\/bgu073","journal-title":"Carcinogenesis"},{"key":"4069_CR24","doi-asserted-by":"publisher","first-page":"117864692092898","DOI":"10.1177\/1178646920928984","volume":"13","author":"A Bosi","year":"2020","unstructured":"Bosi A, Banfi D, Bistoletti M, Giaroni C, Baj A (2020) Tryptophan metabolites along the microbiota-gut-brain axis: an interkingdom communication system influencing the gut in health and disease. Int J Trypto Ress 13:1178646920928984. https:\/\/doi.org\/10.1177\/1178646920928984","journal-title":"Int J Trypto Ress"},{"issue":"3","key":"4069_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Diehl AM (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63(3):764\u2013775. https:\/\/doi.org\/10.1002\/hep.28356","journal-title":"Hepatology"},{"issue":"4","key":"4069_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000448160","volume":"32","author":"A Canbay","year":"2016","unstructured":"Canbay A, Sowa JP, Syn WK, Treckmann J (2016) NASH cirrhosis-the new burden in liver transplantation: how should it be managed? Visc Med 32(4):234\u2013238. https:\/\/doi.org\/10.1159\/000448160","journal-title":"Visc Med"},{"issue":"10","key":"4069_CR27","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1517\/13543784.2014.928279","volume":"23","author":"B Cariou","year":"2014","unstructured":"Cariou B, Staels B (2014) GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes. Expert Opin Investig Drugs 23(10):1441\u20131448. https:\/\/doi.org\/10.1517\/13543784.2014.928279","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"4069_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.soard.2019.12.020","volume":"16","author":"L Castagneto-Gissey","year":"2020","unstructured":"Castagneto-Gissey L, Angelini G, Casella-Mariolo JR, Marini P, Mingrone G, Casella G (2020) The jejunum is the key factor in insulin resistance. Surge Obes Relate Dis 16(4):509\u2013519. https:\/\/doi.org\/10.1016\/j.soard.2019.12.020","journal-title":"Surge Obes Relate Dis"},{"key":"4069_CR29","doi-asserted-by":"publisher","unstructured":"Castagneto-Gissey L, Casella-Mariolo J, Mingrone G (2021) Bariatric\/metabolic surgery. In: From Obesity to Diabetes. Springer, Cham. pp 371\u2013386. https:\/\/doi.org\/10.1007\/978-3-030-53845-2_20","DOI":"10.1007\/978-3-030-53845-2_20"},{"issue":"2","key":"4069_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68(2):763\u2013772. https:\/\/doi.org\/10.1002\/hep.29797","journal-title":"Hepatology"},{"issue":"6353","key":"4069_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.aan0835","volume":"357","author":"L Cervantes-Barragan","year":"2017","unstructured":"Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, Cella M, Gordon JI, Hsieh CS, Colonna M (2017) Lactobacillus reuteri induces gut intraepithelial CD4+ CD8\u03b1\u03b1+ T cells. Science 357(6353):806\u2013810. https:\/\/doi.org\/10.1126\/science.aan0835","journal-title":"Science"},{"key":"4069_CR32","doi-asserted-by":"publisher","unstructured":"Charidemou E (2019) Dietary amino acids and their contribution to de novo lipogenesis. https:\/\/doi.org\/10.17863\/CAM.40126","DOI":"10.17863\/CAM.40126"},{"issue":"4","key":"4069_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jaci.2020.08.008","volume":"146","author":"H Charles-Messance","year":"2020","unstructured":"Charles-Messance H, Mitchelson KA, Castro EDM, Sheedy FJ, Roche HM (2020) Regulating metabolic inflammation by nutritional modulation. J Allergy Clin Immunol 146(4):706\u2013720. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.008","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"4069_CR34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jhep.2012.11.045","volume":"58","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Ganini D, Tokar EJ, Kumar A, Das S, Corbett J, Mason RP (2013) Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. J Hepatol 58(4):778\u2013784. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.045","journal-title":"J Hepatol"},{"issue":"7","key":"4069_CR35","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B (2017) Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152(7):1679\u20131694. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.055","journal-title":"Gastroenterology"},{"key":"4069_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108400","volume":"82","author":"Y Che","year":"2020","unstructured":"Che Y, Shi X, Zhong X, Zhang Y, Si R, Li Y, Shi Y (2020) Resveratrol prevents liver damage in MCD-induced steatohepatitis mice by promoting SIGIRR gene transcription. J Nutr Biochem 82:108400. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108400","journal-title":"J Nutr Biochem"},{"issue":"4","key":"4069_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jdi.12335","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen X, Yang W (2015) Branched-chain amino acids and the association with type 2 diabetes. J Diab Invest 6(4):369\u2013370. https:\/\/doi.org\/10.1111\/jdi.12335","journal-title":"J Diab Invest"},{"key":"4069_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fimmu.2018.01065","volume":"9","author":"B Chen","year":"2018","unstructured":"Chen B, Ni X, Sun R, Zeng B, Wei H, Tian Z, Wei H (2018) Commensal bacteria-dependent CD8\u03b1\u03b2+ T cells in the intestinal epithelium produce antimicrobial peptides. Front Immunol 9:1065. https:\/\/doi.org\/10.3389\/fimmu.2018.01065","journal-title":"Front Immunol"},{"issue":"16","key":"4069_CR39","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3748\/wjg.v26.i16.1901","volume":"26","author":"HT Chen","year":"2020","unstructured":"Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ (2020) Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 26(16):1901. https:\/\/doi.org\/10.3748\/wjg.v26.i16.1901","journal-title":"World J Gastroenterol"},{"key":"4069_CR40","doi-asserted-by":"publisher","first-page":"112314","DOI":"10.1016\/j.fct.2021.112314","volume":"154","author":"L Chen","year":"2021","unstructured":"Chen L, Liu J, Mei G, Chen H, Peng S, Zhao Y, Tang Y (2021) Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis. Food Chem Toxicol 154:112314. https:\/\/doi.org\/10.1016\/j.fct.2021.112314","journal-title":"Food Chem Toxicol"},{"key":"4069_CR41","doi-asserted-by":"publisher","first-page":"1285473","DOI":"10.3389\/fmicb.2023.1285473","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Gan Y, Zhong H, Liu Y, Huang J, Wang W, Geng J (2023) Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease. Front Microbiol 14:1285473. https:\/\/doi.org\/10.3389\/fmicb.2023.1285473","journal-title":"Front Microbiol"},{"key":"4069_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116181","volume":"307","author":"W Cheng","year":"2023","unstructured":"Cheng W, Wang X, Wu Y, Li W, Fu C, Zou L, Zhang J (2023) Huanglian-Houpo extract attenuates DSS-induced UC mice by protecting intestinal mucosal barrier and regulating macrophage polarization. J Ethnopharmacol 307:116181. https:\/\/doi.org\/10.1016\/j.jep.2023.116181","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"4069_CR43","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1021\/acs.jmedchem.9b01621","volume":"63","author":"D Chianelli","year":"2020","unstructured":"Chianelli D, Rucker PV, Roland J, Tully DC, Nelson J, Liu X, Molteni V (2020) Nidufexor (LMB763), a novel FXR modulator for the treatment of nonalcoholic steatohepatitis. J Med Chem 63(8):3868\u20133880. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01621","journal-title":"J Med Chem"},{"key":"4069_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12275-022-1531-0","volume":"60","author":"SH Cho","year":"2022","unstructured":"Cho SH, Cho YJ, Park JH (2022) The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism. J Microbiol 60:118\u2013127. https:\/\/doi.org\/10.1007\/s12275-022-1531-0","journal-title":"J Microbiol"},{"issue":"4","key":"4069_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jnutbio.2011.01.007","volume":"23","author":"MY Chung","year":"2012","unstructured":"Chung MY, Park HJ, Manautou JE, Koo SI, Bruno RS (2012) Green tea extract protects against nonalcoholic steatohepatitis in ob\/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 23(4):361\u2013367. https:\/\/doi.org\/10.1016\/j.jnutbio.2011.01.007","journal-title":"J Nutr Biochem"},{"key":"4069_CR46","doi-asserted-by":"publisher","unstructured":"Circu ML, Aw TY (2012) Intestinal redox biology and oxidative stress. In: Seminars in Cell & Developmental Biology. Academic Press. 23(7):729\u2013737. https:\/\/doi.org\/10.1016\/j.semcdb.2012.03.014","DOI":"10.1016\/j.semcdb.2012.03.014"},{"issue":"3","key":"4069_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14218\/JCTH.2018.00025","volume":"6","author":"JJ Connolly","year":"2018","unstructured":"Connolly JJ, Ooka K, Lim JK (2018) Future pharmacotherapy for non-alcoholic steatohepatitis (NASH): review of phase 2 and 3 trials. Js Clin Transl Hepatol 6(3):264. https:\/\/doi.org\/10.14218\/JCTH.2018.00025","journal-title":"Js Clin Transl Hepatol"},{"issue":"4","key":"4069_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.17","volume":"5","author":"R Corr\u00eaa-Oliveira","year":"2016","unstructured":"Corr\u00eaa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR (2016) Regulation of immune cell function by short-chain fatty acids. Clin Trans Immunol 5(4):e73. https:\/\/doi.org\/10.1038\/cti.2016.17","journal-title":"Clin Trans Immunol"},{"issue":"4","key":"4069_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jcmgh.2019.12.005","volume":"9","author":"TM Darby","year":"2020","unstructured":"Darby TM, Naudin CR, Luo L, Jones RM (2020) Lactobacillus rhamnosus GG\u2013induced expression of leptin in the intestine orchestrates epithelial cell proliferation. Cell Mol Gastroenterol Hepatol 9(4):627\u2013639. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.12.005","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4069_CR50","doi-asserted-by":"publisher","unstructured":"Dash S, Aydin Y, Wu T (2020) Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: a novel mechanism for host-microbe survival and HCC development in liver cirrhosis. In: Seminars in Cell & Developmental Biology. Academic Press. 101:20\u201335. https:\/\/doi.org\/10.1016\/j.semcdb.2019.10.002","DOI":"10.1016\/j.semcdb.2019.10.002"},{"key":"4069_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645168","volume":"12","author":"A De Juan","year":"2021","unstructured":"De Juan A, Segura E (2021) Modulation of immune responses by nutritional ligands of aryl hydrocarbon receptor. Front Immunol 12:645168. https:\/\/doi.org\/10.3389\/fimmu.2021.645168","journal-title":"Front Immunol"},{"issue":"7","key":"4069_CR52","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G Den Besten","year":"2015","unstructured":"Den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Bakker BM (2015) Short-chain fatty acids protect against high-fat diet\u2013induced obesity via a PPAR\u03b3-dependent switch from lipogenesis to fat oxidation. Diabetes 64(7):2398\u20132408. https:\/\/doi.org\/10.2337\/db14-1213","journal-title":"Diabetes"},{"issue":"1","key":"4069_CR53","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12906-022-03715-0","volume":"22","author":"A Deng","year":"2022","unstructured":"Deng A, Liu F, Tang X, Wang Y, Xie P, Yang Q, Xiao B (2022) Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats. BMC Compl Med Ther 22(1):308. https:\/\/doi.org\/10.1186\/s12906-022-03715-0","journal-title":"BMC Compl Med Ther"},{"issue":"Supplement_1","key":"4069_CR54","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2337\/db18-194-LB","volume":"67","author":"A Depaoli","year":"2018","unstructured":"Depaoli A, Rossi SJ, Ling L, Harrison SA, Abdelmalek MF, Jaros MR, Somaratne R (2018) NGM282 significantly reduces hepatic steatosis independent of type 2 diabetes (T2D) status or statin usage\u2014results from a phase 2 trial in patients with nonalcoholic steatohepatitis (NASH). Diabetes 67(Supplement_1):1198\u201311212. https:\/\/doi.org\/10.2337\/db18-194-LB","journal-title":"Diabetes"},{"issue":"4","key":"4069_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4065\/83.4.460","volume":"83","author":"JK DiBaise","year":"2008","unstructured":"DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83(4):460\u2013469. https:\/\/doi.org\/10.4065\/83.4.460","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"4069_CR56","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1002\/cam4.922","volume":"5","author":"Q Ding","year":"2016","unstructured":"Ding Q, Lu P, Xia Y, Ding S, Fan Y, Li X, Liu M (2016) CXCL9: evidence and contradictions for its role in tumor progression. Cancer Med 5(11):3246\u20133259. https:\/\/doi.org\/10.1002\/cam4.922","journal-title":"Cancer Med"},{"key":"4069_CR57","doi-asserted-by":"publisher","first-page":"RP87458","DOI":"10.7554\/eLife.87458","volume":"12","author":"Y Ding","year":"2024","unstructured":"Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, Jayaraman A (2024) Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. Life 12:RP87458. https:\/\/doi.org\/10.7554\/eLife.87458","journal-title":"Life"},{"key":"4069_CR58","doi-asserted-by":"publisher","unstructured":"Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, Menon R, Alaniz RC, Lee K, Jayaraman A\u00a0(2023) Microbially-derived indole-3-acetate alleviates diet induced steatosis and inflammation in mice. eLife 12:RP87458. https:\/\/doi.org\/10.7554\/eLife.87458","DOI":"10.7554\/eLife.87458"},{"issue":"9","key":"4069_CR59","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/nu14091965","volume":"14","author":"MH Do","year":"2022","unstructured":"Do MH, Oh MJ, Lee HB, Kang CH, Yoo G, Park HY (2022) Bifidobacterium animalis ssp lactis MG741 reduces body weight and ameliorates nonalcoholic fatty liver disease via improving the gut permeability and amelioration of inflammatory cytokines. Nutrients 14(9):1965. https:\/\/doi.org\/10.3390\/nu14091965","journal-title":"Nutrients"},{"issue":"3","key":"4069_CR60","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/mmr.2014.2995","volume":"11","author":"A Douhara","year":"2015","unstructured":"Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Fukui H (2015) Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Mol Med Rep 11(3):1693\u20131700. https:\/\/doi.org\/10.3892\/mmr.2014.2995","journal-title":"Mol Med Rep"},{"issue":"1","key":"4069_CR61","first-page":"121614","volume":"4","author":"K Dubey","year":"2024","unstructured":"Dubey K, Singh R (2024) The Gut-Liver Axis in NAFLD Progression: Insights into Pathogenesis and Therapeutic Opportunities. Gut 4(1):121614","journal-title":"Gut"},{"key":"4069_CR62","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3389\/fmicb.2019.01206","volume":"10","author":"R El Hage","year":"2019","unstructured":"El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Props R, Van de Wiele T (2019) Propionate-producing consortium restores antibiotic-induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem. Front Microbiol 10:1206. https:\/\/doi.org\/10.3389\/fmicb.2019.01206","journal-title":"Front Microbiol"},{"issue":"2","key":"4069_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000371692","volume":"33","author":"CO Elson","year":"2015","unstructured":"Elson CO, Alexander KL (2015) Host-microbiota interactions in the intestine. Dig Dis 33(2):131\u2013136. https:\/\/doi.org\/10.1159\/000371692","journal-title":"Dig Dis"},{"issue":"5","key":"4069_CR64","doi-asserted-by":"publisher","first-page":"e63388","DOI":"10.1371\/journal.pone.0063388","volume":"8","author":"H Endo","year":"2013","unstructured":"Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T (2013) Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS ONE 8(5):e63388. https:\/\/doi.org\/10.1371\/journal.pone.0063388","journal-title":"PLoS ONE"},{"key":"4069_CR65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canlet.2019.05.034","volume":"459","author":"N Ezzaidi","year":"2019","unstructured":"Ezzaidi N, Zhang X, Coker OO, Yu J (2019a) New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. Cancer Lett 459:186\u2013191. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.034","journal-title":"Cancer Lett"},{"key":"4069_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canlet.2019.05.027","volume":"459","author":"N Ezzaidi","year":"2019","unstructured":"Ezzaidi N, Zhang X, Coker OO, Yu J (2019b) New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. Cancer Lett 459:186\u2013191. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.027","journal-title":"Cancer Lett"},{"key":"4069_CR67","doi-asserted-by":"publisher","unstructured":"Fatemi Y, Nikfar M, Oladazimi A, Zheng J, Hoy H, Ali H (2024) Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients. In: Healthcare 12(12):1165). MDPI. https:\/\/doi.org\/10.3390\/healthcare12121165","DOI":"10.3390\/healthcare12121165"},{"issue":"3","key":"4069_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15406\/ppij.2020.08.00287","volume":"8","author":"GT Fetene","year":"2020","unstructured":"Fetene GT, Ambachew S, Fasil A, Abebe M (2020) Therapeutic importance of garlic supplementation in the management of nonalcoholic fatty liver disease: A systematic review of preclinical studies. Pharm Pharmacol Int J 8(3):113\u2013120","journal-title":"Pharm Pharmacol Int J"},{"key":"4069_CR69","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S, Biagioli M, Zampella A, Distrutti E (2018) Bile acids activated receptors regulate innate immunity. Front Immunol 9:1853. https:\/\/doi.org\/10.3389\/fimmu.2018.01853","journal-title":"Front Immunol"},{"key":"4069_CR70","unstructured":"Fling RR (2022) Disruptions in Hepatic One Carbon Metabolism and the Gut Microbiome during the Progression of Non-alcoholic Fatty Liver Disease. Michigan State University"},{"issue":"10","key":"4069_CR71","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/lit.2021.41.issue-10","volume":"41","author":"JL Flores-Guerrero","year":"2021","unstructured":"Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, Dullaart RP (2021) Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int 41(10):2371\u20132382. https:\/\/doi.org\/10.1002\/lit.2021.41.issue-10","journal-title":"Liver Int"},{"issue":"2","key":"4069_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/bj20020414","volume":"366","author":"F Foufelle","year":"2002","unstructured":"Foufelle F, Ferre P (2002) New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366(2):377\u2013391. https:\/\/doi.org\/10.1042\/bj20020414","journal-title":"Biochem J"},{"key":"4069_CR73","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S312450","volume":"15","author":"JM Fraile","year":"2021","unstructured":"Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M (2021a) Non-alcoholic steatohepatitis (NASH)\u2013A review of a crowded clinical landscape, driven by a complex disease. Drug Des Dev Ther 15:3997\u20134009. https:\/\/doi.org\/10.2147\/DDDT.S312450","journal-title":"Drug Des Dev Ther"},{"key":"4069_CR74","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT","volume":"15","author":"JM Fraile","year":"2021","unstructured":"Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M (2021b) Non-alcoholic steatohepatitis (NASH)\u2013A review of a crowded clinical landscape, driven by a complex disease. Drug Des Dev Ther 15:3997\u20134009. https:\/\/doi.org\/10.2147\/DDDT","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"4069_CR75","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s42255-020-0257-3","volume":"2","author":"J Frampton","year":"2020","unstructured":"Frampton J, Murphy KG, Frost G, Chambers ES (2020) Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat Metab 2(9):840\u2013848. https:\/\/doi.org\/10.1038\/s42255-020-0257-3","journal-title":"Nat Metab"},{"issue":"10","key":"4069_CR76","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14(10):576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","journal-title":"Nat Rev Endocrinol"},{"issue":"17","key":"4069_CR77","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Abdelmalek MF (2021) A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH. N Engl J Med 385(17):1547\u20131558. https:\/\/doi.org\/10.1056\/NEJMoa2036205","journal-title":"N Engl J Med"},{"issue":"4","key":"4069_CR78","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cgh.2018.07.012","volume":"17","author":"CT Frenette","year":"2019","unstructured":"Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Hagerty DT (2019) Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo. Clin Gastroenterol Hepatol 17(4):774\u2013783. https:\/\/doi.org\/10.1016\/j.cgh.2018.07.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4069_CR79","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.cct.2016.02.012","volume":"47","author":"S Friedman","year":"2016","unstructured":"Friedman S, Sanyal A, Goodman Z, Lefebvre E, Gottwald M, Fischer L, Ratziu V (2016) Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design. Contemp Clin Trials 47:356\u2013365. https:\/\/doi.org\/10.1016\/j.cct.2016.02.012","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"4069_CR80","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/hep.29477","volume":"67","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Ratziu V, Harrison SA, Abdelmalek MF, Aithal GP, Caballeria J, Lefebvre E (2018) A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology 67(5):1754\u20131767. https:\/\/doi.org\/10.1002\/hep.29477","journal-title":"Hepatology"},{"key":"4069_CR81","doi-asserted-by":"publisher","first-page":"973366","DOI":"10.3389\/fphar.2022.973366","volume":"13","author":"Y Fu","year":"2022","unstructured":"Fu Y, Zhou Y, Shen L, Li X, Zhang H, Cui Y, Ye W (2022) Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease. Front Pharmacol 13:973366. https:\/\/doi.org\/10.3389\/fphar.2022.973366","journal-title":"Front Pharmacol"},{"key":"4069_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111781","volume":"140","author":"SH Gadallah","year":"2021","unstructured":"Gadallah SH, Eissa S, Ghanem HM, Ahmed EK, Hasanin AH, El Mahdy MM, Matboli M (2021) Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs\/miR-1205\/lncRNA SRD5A3-AS1) panel in NASH animal model. Biomed Pharmacother 140:111781. https:\/\/doi.org\/10.1016\/j.biopha.2021.111781","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4069_CR83","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu CL, Farzi A, Zhu WY (2020) Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr 11(3):709\u2013723. https:\/\/doi.org\/10.1093\/advances\/nmz127","journal-title":"Adv Nutr"},{"issue":"5","key":"4069_CR84","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jhep.2019.11.021","volume":"72","author":"G Garcia-Tsao","year":"2020","unstructured":"Garcia-Tsao G, Bosch J, Kayali Z, Harrison SA, Abdelmalek MF, Lawitz E, Muellhaupt B (2020) Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. J Hepatol 72(5):885\u2013895. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.021","journal-title":"J Hepatol"},{"issue":"22","key":"4069_CR85","doi-asserted-by":"publisher","first-page":"12190","DOI":"10.3390\/ijms222212190","volume":"22","author":"YA Gebru","year":"2021","unstructured":"Gebru YA, Gupta H, Kim HS, Eom JA, Kwon GH, Park E, Suk KT (2021) T cell subsets and natural killer cells in the pathogenesis of nonalcoholic fatty liver disease. Int J Mol Sci 22(22):12190. https:\/\/doi.org\/10.3390\/ijms222212190","journal-title":"Int J Mol Sci"},{"key":"4069_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10061-1","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H (2021) How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hep Intl 15:21\u201335. https:\/\/doi.org\/10.1007\/s12072-020-10061-1","journal-title":"Hep Intl"},{"issue":"10","key":"4069_CR87","doi-asserted-by":"publisher","first-page":"eaai7616","DOI":"10.1126\/sciimmunol.aai7616","volume":"2","author":"M Ghazarian","year":"2017","unstructured":"Ghazarian M, Revelo XS, N\u00f8hr MK, Luck H, Zeng K, Lei H, Winer DA (2017) Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome. Sci Immunol 2(10):eaai7616. https:\/\/doi.org\/10.1126\/sciimmunol.aai7616","journal-title":"Sci Immunol"},{"issue":"1","key":"4069_CR88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MCO.0000000000000236","volume":"19","author":"P Giesbertz","year":"2016","unstructured":"Giesbertz P, Daniel H (2016) Branched-chain amino acids as biomarkers in diabetes. Curr Opin Clin Nutr Metab Care 19(1):48\u201354. https:\/\/doi.org\/10.1097\/MCO.0000000000000236","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"4069_CR89","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Glass, O., Filozof, C., Noureddin, M., Berner-Hansen, M., Schabel, E., Omokaro, S. O., & Liver Forum Standard of Care Working Group","year":"2020","unstructured":"Glass, O., Filozof, C., Noureddin, M., Berner-Hansen, M., Schabel, E., Omokaro, S. O., & Liver Forum Standard of Care Working Group (2020) Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. J Hepatol 73(3):680\u2013693. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.006","journal-title":"J Hepatol"},{"issue":"6","key":"4069_CR90","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep4.1349","volume":"3","author":"A Guillot","year":"2019","unstructured":"Guillot A, Tacke F (2019) Liver macrophages: old dogmas and new insights. Hepatol Commun 3(6):730\u2013743. https:\/\/doi.org\/10.1002\/hep4.1349","journal-title":"Hepatol Commun"},{"issue":"7","key":"4069_CR91","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000491","volume":"8","author":"A Guillot","year":"2024","unstructured":"Guillot A, Tacke F (2024) Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context. Hepatol Commun 8(7):e0491. https:\/\/doi.org\/10.1097\/HC9.0000000000000491","journal-title":"Hepatol Commun"},{"issue":"2","key":"4069_CR92","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/10600280221150120","volume":"59","author":"E Guirguis","year":"2025","unstructured":"Guirguis E, Dougherty J, Thornby K, Grace Y, Mack K (2025) Resmetirom: The First Food and Drug Administration-Approved Medication for Nonalcoholic Steatohepatitis (NASH). Ann Pharmacother 59(2):162\u2013173. https:\/\/doi.org\/10.1177\/10600280221150120","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4069_CR93","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/biomedicines10030550","volume":"10","author":"H Gupta","year":"2022","unstructured":"Gupta H, Min BH, Ganesan R, Gebru YA, Sharma SP, Park E, Suk KT (2022) Gut microbiome in non-alcoholic fatty liver disease: from mechanisms to therapeutic role. Biomedicines 10(3):550. https:\/\/doi.org\/10.3390\/biomedicines10030550","journal-title":"Biomedicines"},{"key":"4069_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00996-w","volume":"9","author":"H Han","year":"2021","unstructured":"Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, Zhang H (2021) From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome 9:1\u201316. https:\/\/doi.org\/10.1186\/s40168-020-00996-w","journal-title":"Microbiome"},{"key":"4069_CR95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2016.12.002","volume":"53","author":"L Hannibal","year":"2017","unstructured":"Hannibal L, Blom HJ (2017) Homocysteine and disease: causal associations or epiphenomenons? Mol Aspects Med 53:36\u201342. https:\/\/doi.org\/10.1016\/j.mam.2016.12.002","journal-title":"Mol Aspects Med"},{"issue":"2","key":"4069_CR96","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ilar\/ilv023","volume":"56","author":"AK Hansen","year":"2015","unstructured":"Hansen AK, Krych \u0141, Nielsen DS, Hansen CHF (2015) A review of applied aspects of dealing with gut microbiota impact on rodent models. ILAR J 56(2):250\u2013264. https:\/\/doi.org\/10.1093\/ilar\/ilv023","journal-title":"ILAR J"},{"key":"4069_CR97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/DDDT.S000000","volume":"19","author":"L Hao","year":"2025","unstructured":"Hao L, Li S, Li C, Zhang Z, Hu X, Yan H (2025) A review of the therapeutic potential of ginseng and its bioactive components in nonalcoholic fatty liver disease. Drug des Dev Ther 19:83\u201396. https:\/\/doi.org\/10.2147\/DDDT.S000000","journal-title":"Drug des Dev Ther"},{"key":"4069_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.027","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, Wong V, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Younossi Z (2020a) Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from the STELLAR Phase 3 Trials. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.02.027","journal-title":"J Hepatol"},{"issue":"5","key":"4069_CR99","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, Goodman Z, Jabbar A, Vemulapalli R, Younes ZH, Freilich B, Sanyal AJ (2020b) A randomized, placebo-controlled trial of emricasan in patients with NASH and F1\u2013F3 fibrosis. J Hepatol 72(5):816\u2013827. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.020","journal-title":"J Hepatol"},{"issue":"1","key":"4069_CR100","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, Wong V, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Younossi Z (2020c) Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from the STELLAR phase 3 trials. J Hepatol 73(1):26\u201339. https:\/\/doi.org\/10.1016\/j.jhep.2020.02.027","journal-title":"J Hepatol"},{"issue":"6","key":"4069_CR101","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Ratziu V (2024a) A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 390(6):497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2309000","journal-title":"N Engl J Med"},{"issue":"6","key":"4069_CR102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2303941","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Ratziu V (2024b) A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 390(6):497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2303941","journal-title":"N Engl J Med"},{"issue":"5","key":"4069_CR103","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41401-021-00795-0","volume":"43","author":"BE Harvey","year":"2022","unstructured":"Harvey BE (2022) NASH: regulatory considerations for clinical drug development and US FDA approval. Acta Pharmacol Sin 43(5):1210\u20131214. https:\/\/doi.org\/10.1038\/s41401-021-00795-0","journal-title":"Acta Pharmacol Sin"},{"key":"4069_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.761836","volume":"12","author":"LH He","year":"2021","unstructured":"He LH, Yao DH, Wang LY, Zhang L, Bai XL (2021) Gut microbiome-mediated alteration of immunity, inflammation, and metabolism involved in the regulation of non-alcoholic fatty liver disease. Front Microbiol 12:761836. https:\/\/doi.org\/10.3389\/fmicb.2021.761836","journal-title":"Front Microbiol"},{"issue":"7","key":"4069_CR105","doi-asserted-by":"publisher","first-page":"e004947","DOI":"10.1161\/JAHA.116.004947","volume":"6","author":"Y Heianza","year":"2017","unstructured":"Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc 6(7):e004947. https:\/\/doi.org\/10.1161\/JAHA.116.004947","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"4069_CR106","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/21623945.2016.1247831","volume":"5","author":"E Heimann","year":"2016","unstructured":"Heimann E, Nyman M, P\u00e5lbrink AK, Lindkvist-Petersson K, Degerman E (2016) Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. Adipocyte 5(4):359\u2013368. https:\/\/doi.org\/10.1080\/21623945.2016.1247831","journal-title":"Adipocyte"},{"issue":"8","key":"4069_CR107","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/hep4.1381","volume":"3","author":"ED Hernandez","year":"2019","unstructured":"Hernandez ED, Zheng L, Kim Y, Fang B, Liu B, Valdez RA, Laffitte B (2019) Tropifexor-mediated abrogation of steatohepatitis and fibrosis is associated with the antioxidative gene expression profile in rodents. Hepatol Commun 3(8):1085\u20131097. https:\/\/doi.org\/10.1002\/hep4.1381","journal-title":"Hepatol Commun"},{"issue":"5","key":"4069_CR108","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1753-4887.2011.00388.x","volume":"69","author":"E Hosseini","year":"2011","unstructured":"Hosseini E, Grootaert C, Verstraete W, Van de Wiele T (2011) Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev 69(5):245\u2013258. https:\/\/doi.org\/10.1111\/j.1753-4887.2011.00388.x","journal-title":"Nutr Rev"},{"issue":"40","key":"4069_CR109","doi-asserted-by":"publisher","first-page":"E9499","DOI":"10.1073\/pnas.1807791115","volume":"115","author":"Z Huang","year":"2018","unstructured":"Huang Z, Zhang M, Plec AA, Estill SJ, Cai L, Repa JJ, Tu BP (2018) ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism. Proc Natl Acad Sci 115(40):E9499\u2013E9506. https:\/\/doi.org\/10.1073\/pnas.1807791115","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"4069_CR110","doi-asserted-by":"publisher","first-page":"159209","DOI":"10.1016\/j.bbalip.2022.159209","volume":"1867","author":"CC Hughey","year":"2022","unstructured":"Hughey CC, Puchalska P, Crawford PA (2022) Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis. Biochimica et Biophysica Acta BBA Molecular and Cell Biology of Lipids 1867(11):159209. https:\/\/doi.org\/10.1016\/j.bbalip.2022.159209","journal-title":"Biochimica et Biophysica Acta BBA Molecular and Cell Biology of Lipids"},{"issue":"6","key":"4069_CR111","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cmet.2020.10.010","volume":"32","author":"JY Huh","year":"2020","unstructured":"Huh JY, Reilly SM, Abu-Odeh M, Murphy AN, Mahata SK, Zhang J, Saltiel AR (2020) TANK-binding kinase 1 regulates the localization of acyl-CoA synthetase ACSL1 to control hepatic fatty acid oxidation. Cell Metab 32(6):1012-1027.e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.010","journal-title":"Cell Metab"},{"key":"4069_CR112","unstructured":"Hussain R, Alam S, Iqbal Z, Ali HM, Khan Z, Mahmood K, Qamar MR (2021) Mitigation of Enteric Pathogens and Modulation of Gut Microbiota in Livestock by Natural Feed Additives. In: Complementary and Alternative Medicine: Feed Additives. Springer. pp 125\u2013145. https:\/\/doi.org\/10.1007\/978-3-030-57309-9_7"},{"issue":"07","key":"4069_CR113","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1142\/S0192415X23500700","volume":"51","author":"CH Hwang","year":"2023","unstructured":"Hwang CH, Jang E, Lee JH (2023) Pharmacological benefits and underlying mechanisms of Salvia miltiorrhiza against molecular pathology of various liver diseases: A review. Am J Chin Med 51(07):1675\u20131709. https:\/\/doi.org\/10.1142\/S0192415X23500700","journal-title":"Am J Chin Med"},{"issue":"2","key":"4069_CR114","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/nu9020181","volume":"9","author":"K Iizuka","year":"2017","unstructured":"Iizuka K (2017) The role of carbohydrate response element binding protein in intestinal and hepatic fructose metabolism. Nutrients 9(2):181. https:\/\/doi.org\/10.3390\/nu9020181","journal-title":"Nutrients"},{"issue":"5","key":"4069_CR115","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.4049\/jimmunol.0803650","volume":"182","author":"AS Ismail","year":"2009","unstructured":"Ismail AS, Behrendt CL, Hooper LV (2009) Reciprocal interactions between commensal bacteria and \u03b3\u03b4 intraepithelial lymphocytes during mucosal injury. J Immunol 182(5):3047\u20133054. https:\/\/doi.org\/10.4049\/jimmunol.0803650","journal-title":"J Immunol"},{"issue":"3","key":"4069_CR116","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/mi.2010.3","volume":"3","author":"II Ivanov","year":"2010","unstructured":"Ivanov II, Littman DR (2010) Segmented filamentous bacteria take the stage. Mucosal Immunol 3(3):209\u2013212. https:\/\/doi.org\/10.1038\/mi.2010.3","journal-title":"Mucosal Immunol"},{"key":"4069_CR117","doi-asserted-by":"publisher","unstructured":"Jadeja RN, Devkar RV (2014) Polyphenols and flavonoids in controlling non-alcoholic steatohepatitis. In Polyphenols in Human Health and Disease. Academic Press. pp 615\u2013623. https:\/\/doi.org\/10.1016\/B978-0-12-398456-2.00042-0","DOI":"10.1016\/B978-0-12-398456-2.00042-0"},{"issue":"6","key":"4069_CR118","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4239\/wjd.v12.i6.730","volume":"12","author":"HR Jang","year":"2021","unstructured":"Jang HR, Lee HY (2021) Mechanisms linking gut microbial metabolites to insulin resistance. World J Diabetes 12(6):730\u2013744. https:\/\/doi.org\/10.4239\/wjd.v12.i6.730","journal-title":"World J Diabetes"},{"issue":"8","key":"4069_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0344","volume":"51","author":"HR Jang","year":"2019","unstructured":"Jang HR, Park HJ, Kang D, Chung H, Nam MH, Lee Y, Park JH, Lee HY (2019) A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption. Exp Mol Med 51(8):1\u201314. https:\/\/doi.org\/10.1038\/s12276-019-0344","journal-title":"Exp Mol Med"},{"key":"4069_CR120","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jnutbio.2018.04.011","volume":"57","author":"PK Jena","year":"2018","unstructured":"Jena PK, Sheng L, Nagar N, Wu C, Barile D, Mills DA, Wan YJY (2018) Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models. J Nutr Biochem 57:246\u2013254. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.04.011","journal-title":"J Nutr Biochem"},{"issue":"8","key":"4069_CR121","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu11081712","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji Y, Yin Y, Li Z, Zhang W (2019a) Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients 11(8):1712. https:\/\/doi.org\/10.3390\/nu11081712","journal-title":"Nutrients"},{"issue":"9","key":"4069_CR122","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/nu11092062","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji Y, Gao Y, Chen H, Yin Y, Zhang W (2019b) Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress. Nutrients 11(9):2062. https:\/\/doi.org\/10.3390\/nu11092062","journal-title":"Nutrients"},{"key":"4069_CR123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2018.10.019","volume":"440","author":"N Ji","year":"2019","unstructured":"Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Chen ZS (2019c) Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells. Cancer Lett 440:82\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2018.10.019","journal-title":"Cancer Lett"},{"issue":"9","key":"4069_CR124","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3390\/ijms21093066","volume":"21","author":"Y Ji","year":"2020","unstructured":"Ji Y, Yin Y, Sun L, Zhang W (2020) The molecular and mechanistic insights based on gut\u2013liver axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement. Int J Mol Sci 21(9):3066. https:\/\/doi.org\/10.3390\/ijms21093066","journal-title":"Int J Mol Sci"},{"key":"4069_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.841132","volume":"13","author":"J Jian","year":"2022","unstructured":"Jian J, Nie MT, Xiang B, Qian H, Yin C, Zhang X, Xie WF (2022) Rifaximin ameliorates non-alcoholic steatohepatitis in mice through regulating gut microbiome-related bile acids. Front Pharmacol 13:841132. https:\/\/doi.org\/10.3389\/fphar.2022.841132","journal-title":"Front Pharmacol"},{"issue":"8","key":"4069_CR126","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1152\/physiolgenomics.00010.2021","volume":"53","author":"N Jiao","year":"2021","unstructured":"Jiao N, Loomba R, Yang ZH, Wu D, Fang S, Bettencourt R, Zhu L (2021) Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. Physiol Genomics 53(8):336\u2013348. https:\/\/doi.org\/10.1152\/physiolgenomics.00010.2021","journal-title":"Physiol Genomics"},{"issue":"10","key":"4069_CR127","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.biochi.2012.06.031","volume":"94","author":"N Joffin","year":"2012","unstructured":"Joffin N, Niang F, Forest C, Jaubert AM (2012) Is there NO help for leptin? Biochimie 94(10):2104\u20132110. https:\/\/doi.org\/10.1016\/j.biochi.2012.06.031","journal-title":"Biochimie"},{"key":"4069_CR128","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/S0618-8278(20)30386-7","volume":"73","author":"MP Johnston","year":"2020","unstructured":"Johnston MP, Jennison E, Cook C, Jamal R, Byrne C, Patel J (2020) A substantial number of patients with non-alcoholic fatty liver disease and type 2 diabetes have advanced liver fibrosis with a normal serum alanine transaminase. J Hepatol 73:S123\u2013S400. https:\/\/doi.org\/10.1016\/S0618-8278(20)30386-7","journal-title":"J Hepatol"},{"issue":"23","key":"4069_CR129","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1038\/emboj.2013.224","volume":"32","author":"RM Jones","year":"2013","unstructured":"Jones RM, Luo L, Ardita CS, Richardson AN, Kwon YM, Mercante JW, Neish AS (2013) Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 32(23):3017\u20133028. https:\/\/doi.org\/10.1038\/emboj.2013.224","journal-title":"EMBO J"},{"issue":"8","key":"4069_CR130","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.celrep.2015.07.043","volume":"12","author":"RM Jones","year":"2015","unstructured":"Jones RM, Desai C, Darby TM, Luo L, Wolfarth AA, Scharer CD, Neish AS (2015) Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep 12(8):1217\u20131225. https:\/\/doi.org\/10.1016\/j.celrep.2015.07.043","journal-title":"Cell Rep"},{"issue":"9","key":"4069_CR131","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","volume":"22","author":"CA Juan","year":"2021","unstructured":"Juan CA, P\u00e9rez de la Lastra JM, Plou FJ, P\u00e9rez-Lebe\u00f1a E (2021) The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci 22(9):4642. https:\/\/doi.org\/10.3390\/ijms22094642","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4069_CR132","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14348\/molcells.2019.0015","volume":"42","author":"J Jung","year":"2019","unstructured":"Jung J, Surh CD, Lee YJ (2019) Microbial colonization at early life promotes the development of diet-induced CD8\u03b1\u03b2 intraepithelial T cells. Mol Cells 42(4):313\u2013320. https:\/\/doi.org\/10.14348\/molcells.2019.0015","journal-title":"Mol Cells"},{"issue":"1","key":"4069_CR133","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jhep.2024.09.012","volume":"82","author":"WSS J\u00fanior","year":"2025","unstructured":"J\u00fanior WSS, Sposito AC, Godoy-Matos A (2025) Should the new EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy? J Hepatol 82(1):e21\u2013e22. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.012","journal-title":"J Hepatol"},{"issue":"3","key":"4069_CR134","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60(3):404\u2013413. https:\/\/doi.org\/10.1016\/j.metabol.2010.03.006","journal-title":"Metabolism"},{"issue":"9","key":"4069_CR135","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/intimm\/dxac033","volume":"34","author":"T Kamiya","year":"2022","unstructured":"Kamiya T, Ohtani N (2022) The role of immune cells in the liver tumor microenvironment: An involvement of gut microbiota-derived factors. Int Immunol 34(9):467\u2013474. https:\/\/doi.org\/10.1093\/intimm\/dxac033","journal-title":"Int Immunol"},{"issue":"1","key":"4069_CR136","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chembiol.2018.10.003","volume":"26","author":"JD Kang","year":"2019","unstructured":"Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS, Hylemon PB (2019) Bile acid 7\u03b1-dehydroxylating gut bacteria secrete antibiotics that inhibit Clostridium difficile: role of secondary bile acids. Cell Chem Biol 26(1):27\u201334. https:\/\/doi.org\/10.1016\/j.chembiol.2018.10.003","journal-title":"Cell Chem Biol"},{"issue":"6","key":"4069_CR137","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, El-Serag HB (2018) Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology 155(6):1828\u20131837. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.024","journal-title":"Gastroenterology"},{"issue":"2","key":"4069_CR138","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/17474124.2.2.233","volume":"2","author":"KR Karlmark","year":"2008","unstructured":"Karlmark KR, Wasmuth HE, Trautwein C, Tacke F (2008) Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2(2):233\u2013242. https:\/\/doi.org\/10.1586\/17474124.2.2.233","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"4069_CR139","doi-asserted-by":"publisher","first-page":"e00503","DOI":"10.14309\/ctg.0000000000000503","volume":"13","author":"Y Kasai","year":"2022","unstructured":"Kasai Y, Kessoku T, Tanaka K, Yamamoto A, Takahashi K, Kobayashi T, Nakajima A (2022) Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational study. Clin Transl Gastroenterol 13(7):e00503","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"4069_CR140","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/nu7042839","volume":"7","author":"M Kasubuchi","year":"2015","unstructured":"Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7(4):2839\u20132849. https:\/\/doi.org\/10.3390\/nu7042839","journal-title":"Nutrients"},{"issue":"3","key":"4069_CR141","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cardiores.2005.02.007","volume":"66","author":"N Kawamura","year":"2005","unstructured":"Kawamura N, Kubota T, Kawano S, Monden Y, Feldman AM, Tsutsui H, Sunagawa K (2005) Blockade of NF-\u03baB improves cardiac function and survival without affecting inflammation in TNF-\u03b1-induced cardiomyopathy. Cardiovasc Res 66(3):520\u2013529. https:\/\/doi.org\/10.1016\/j.cardiores.2005.02.007","journal-title":"Cardiovasc Res"},{"issue":"43","key":"4069_CR142","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.3748\/wjg.14.6655","volume":"14","author":"H Kawaratani","year":"2008","unstructured":"Kawaratani H, Tsujimoto T, Kitazawa T, Kitade M, Yoshiji H, Uemura M, Fukui H (2008) Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. World J Gastroenterol 14(43):6655\u20136660. https:\/\/doi.org\/10.3748\/wjg.14.6655","journal-title":"World J Gastroenterol"},{"key":"4069_CR143","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-071219-125933","volume":"38","author":"H Kayama","year":"2020","unstructured":"Kayama H, Okumura R, Takeda K (2020) Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol 38:23\u201348. https:\/\/doi.org\/10.1146\/annurev-immunol-071219-125933","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"4069_CR144","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7150\/ijbs.55836","volume":"17","author":"A Khan","year":"2021","unstructured":"Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Guo X (2021) Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates. Int J Biol Sci 17(3):818. https:\/\/doi.org\/10.7150\/ijbs.55836","journal-title":"Int J Biol Sci"},{"issue":"12","key":"4069_CR145","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","volume":"15","author":"CW Kheong","year":"2017","unstructured":"Kheong CW, Mustapha NRN, Mahadeva S (2017) A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 15(12):1940\u20131949. https:\/\/doi.org\/10.1016\/j.cgh.2017.04.016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4069_CR146","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3350\/cmh.2021.0109","volume":"27","author":"HY Kim","year":"2021","unstructured":"Kim HY (2021) Recent advances in nonalcoholic fatty liver disease metabolomics. Clin Mol Hepatol 27(4):553\u2013569. https:\/\/doi.org\/10.3350\/cmh.2021.0109","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"4069_CR147","doi-asserted-by":"publisher","first-page":"129834","DOI":"10.1016\/j.bbagen.2020.129834","volume":"1865","author":"KH Kim","year":"2021","unstructured":"Kim KH, Lee MS (2021) GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH. Biochimica et Biophysica Acta BBA - General Subjects 1865(3):129834. https:\/\/doi.org\/10.1016\/j.bbagen.2020.129834","journal-title":"Biochimica et Biophysica Acta BBA - General Subjects"},{"issue":"11","key":"4069_CR148","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"DY Kim","year":"2023","unstructured":"Kim DY, Park JY, Gee HY (2023a) Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating L-arginine production. Exp Mol Med 55(11):2332\u20132345. https:\/\/doi.org\/10.1038\/s12276-023-01020-1","journal-title":"Exp Mol Med"},{"issue":"10","key":"4069_CR149","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/microorganisms11102466","volume":"11","author":"H Kim","year":"2023","unstructured":"Kim H, Lee K, Kim JY, Shim JJ, Lim J, Kim JY, Lee JL (2023b) Lactobacillus helveticus isolated from raw milk improves liver function, hepatic steatosis, and lipid metabolism in non-alcoholic fatty liver disease mouse model. Microorganisms 11(10):2466. https:\/\/doi.org\/10.3390\/microorganisms11102466","journal-title":"Microorganisms"},{"key":"4069_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111565","volume":"128","author":"M Kim","year":"2024","unstructured":"Kim M, Jeong B, Lee G, Jeon H, Yang YM, Yang H, Han Y (2024) Panaxydol extracted from Panax ginseng inhibits NLRP3 inflammasome activation to ameliorate NASH-induced liver injury. Int Immunopharmacol 128:111565. https:\/\/doi.org\/10.1016\/j.intimp.2024.111565","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4069_CR151","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2019","unstructured":"Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M (2019) Free fatty acid receptors in health and disease. Physiol Rev 100(1):171\u2013210. https:\/\/doi.org\/10.1152\/physrev.00041.2018","journal-title":"Physiol Rev"},{"issue":"13\u201314","key":"4069_CR152","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","volume":"48","author":"IA Kirpich","year":"2015","unstructured":"Kirpich IA, Marsano LS, McClain CJ (2015) Gut\u2013liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem 48(13\u201314):923\u2013930. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.023","journal-title":"Clin Biochem"},{"key":"4069_CR153","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jff.2017.11.049","volume":"40","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak N, Abenavoli L, Mykhalchyshyn G, Kononenko L, Boccuto L, Kyriienko D, Dynnyk O (2018) A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. J Funct Foods 40:341\u2013349. https:\/\/doi.org\/10.1016\/j.jff.2017.11.049","journal-title":"J Funct Foods"},{"issue":"4","key":"4069_CR154","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2020.03.005","volume":"78","author":"A Koh","year":"2020","unstructured":"Koh A, B\u00e4ckhed F (2020) From association to causality: the role of the gut microbiota and its functional products on host metabolism. Mol Cell 78(4):584\u2013596. https:\/\/doi.org\/10.1016\/j.molcel.2020.03.005","journal-title":"Mol Cell"},{"issue":"7","key":"4069_CR155","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/antiox9070610","volume":"9","author":"Y Kong","year":"2020","unstructured":"Kong Y, Olejar KJ, On SL, Chelikani V (2020) The potential of Lactobacillus spp. for modulating oxidative stress in the gastrointestinal tract. Antioxidants 9(7):610. https:\/\/doi.org\/10.3390\/antiox9070610","journal-title":"Antioxidants"},{"issue":"3","key":"4069_CR156","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/medsci6030079","volume":"6","author":"PC Konturek","year":"2018","unstructured":"Konturek PC, Harsch IA, Konturek K, Schink M, Konturek T, Neurath MF, Zopf Y (2018) Gut-liver axis: How do gut bacteria influence the liver? Med Sci 6(3):79. https:\/\/doi.org\/10.3390\/medsci6030079","journal-title":"Med Sci"},{"issue":"4","key":"4069_CR157","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel O, Puengel T, Govaere O, Abdallah AT, Mossanen JC, Kohlhepp M, Tacke F (2018) Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67(4):1270\u20131283. https:\/\/doi.org\/10.1002\/hep.29544","journal-title":"Hepatology"},{"issue":"1","key":"4069_CR158","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14218\/JCTH.2019.00020","volume":"8","author":"R Kumar","year":"2019","unstructured":"Kumar R, Priyadarshi RN, Anand U (2019) Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations. J Clin Transl Hepatol 8(1):76. https:\/\/doi.org\/10.14218\/JCTH.2019.00020","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"4069_CR159","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/biomedicines11051388","volume":"11","author":"C Kunst","year":"2023","unstructured":"Kunst C, Schmid S, Michalski M, T\u00fcmen D, Buttensch\u00f6n J, M\u00fcller M, G\u00fclow K (2023) The influence of gut microbiota on oxidative stress and the immune system. Biomedicines 11(5):1388. https:\/\/doi.org\/10.3390\/biomedicines11051388","journal-title":"Biomedicines"},{"issue":"1","key":"4069_CR160","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/hmbci-2015-0016","volume":"22","author":"G Lastra","year":"2015","unstructured":"Lastra G, Manrique C (2015) Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease. Horm Mol Biol Clin Invest 22(1):19\u201326. https:\/\/doi.org\/10.1515\/hmbci-2015-0016","journal-title":"Horm Mol Biol Clin Invest"},{"issue":"9","key":"4069_CR161","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5483\/bmbrep.2018.51.9.167","volume":"51","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Cha JY (2018) Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism. BMB Rep 51(9):429\u2013436. https:\/\/doi.org\/10.5483\/bmbrep.2018.51.9.167","journal-title":"BMB Rep"},{"issue":"2","key":"4069_CR162","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4166\/kjg.2012.60.2.86","volume":"60","author":"S Lee","year":"2012","unstructured":"Lee S, Yang K, Cheon JH, Kim TI, Kim WH (2012) Anti-inflammatory mechanism of Lactobacillus rhamnosus GG in lipopolysaccharide-stimulated HT-29 cell. Korean J Gastroenterol 60(2):86\u201393. https:\/\/doi.org\/10.4166\/kjg.2012.60.2.86","journal-title":"Korean J Gastroenterol"},{"key":"4069_CR163","doi-asserted-by":"publisher","first-page":"116735","DOI":"10.1016\/j.biopha.2023.116735","volume":"175","author":"DH Lee","year":"2024","unstructured":"Lee DH, Kim MT, Han JH (2024) GPR41 and GPR43: From development to metabolic regulation. Biomed Pharmacother 175:116735. https:\/\/doi.org\/10.1016\/j.biopha.2023.116735","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4069_CR164","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89(1):147\u2013191. https:\/\/doi.org\/10.1152\/physrev.00010.2008","journal-title":"Physiol Rev"},{"issue":"1","key":"4069_CR165","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","volume":"1","author":"S Lefere","year":"2019","unstructured":"Lefere S, Tacke F (2019) Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. JHEP Reports 1(1):30\u201343. https:\/\/doi.org\/10.1016\/j.jhepr.2019.02.004","journal-title":"JHEP Reports"},{"issue":"648","key":"4069_CR166","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1126\/scitranslmed.abk0855","volume":"14","author":"H Leung","year":"2022","unstructured":"Leung H, Long X, Ni Y, Qian L, Nychas E, Siliceo SL, Panagiotou G (2022) Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med 14(648):855. https:\/\/doi.org\/10.1126\/scitranslmed.abk0855","journal-title":"Sci Transl Med"},{"issue":"10","key":"4069_CR167","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/metabo9100233","volume":"9","author":"M L\u00e9veill\u00e9","year":"2019","unstructured":"L\u00e9veill\u00e9 M, Estall JL (2019) Mitochondrial dysfunction in the transition from NASH to HCC. Metabolites 9(10):233. https:\/\/doi.org\/10.3390\/metabo9100233","journal-title":"Metabolites"},{"key":"4069_CR168","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jnutbio.2016.12.014","volume":"41","author":"J Li","year":"2017","unstructured":"Li J, Sapper TN, Mah E, Moller MV, Kim JB, Chitchumroonchokchai C, Bruno RS (2017) Green tea extract treatment reduces NF\u03baB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability. J Nutr Biochem 41:34\u201341. https:\/\/doi.org\/10.1016\/j.jnutbio.2016.12.014","journal-title":"J Nutr Biochem"},{"issue":"4","key":"4069_CR169","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/jbmr.3648","volume":"34","author":"Z Li","year":"2019","unstructured":"Li Z, Huang J, Wang F, Li W, Wu X, Zhao C, Xiao J (2019) Dual targeting of bile acid receptor-1 (TGR5) and farnesoid X receptor (FXR) prevents estrogen-dependent bone loss in mice. J Bone Miner Res 34(4):765\u2013776. https:\/\/doi.org\/10.1002\/jbmr.3648","journal-title":"J Bone Miner Res"},{"key":"4069_CR170","doi-asserted-by":"publisher","first-page":"1451084","DOI":"10.3389\/fphar.2024.1451084","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Hao L, Yu F, Li N, Deng J, Zhang J, Hu X (2024a) Capsaicin: a spicy way in liver disease. Front Pharmacol 15:1451084. https:\/\/doi.org\/10.3389\/fphar.2024.1451084","journal-title":"Front Pharmacol"},{"issue":"1","key":"4069_CR171","doi-asserted-by":"publisher","first-page":"2304159","DOI":"10.1080\/19490976.2023.2304159","volume":"16","author":"H Li","year":"2024","unstructured":"Li H, Wang XK, Tang M, Lei L, Li JR, Sun H, Peng ZG (2024b) Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism. Gut Microbes 16(1):2304159. https:\/\/doi.org\/10.1080\/19490976.2023.2304159","journal-title":"Gut Microbes"},{"issue":"1","key":"4069_CR172","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000381","volume":"7","author":"CW Liu","year":"2020","unstructured":"Liu CW, Huang CC, Hsu CF, Li TH, Tsai YL, Lin MW, Lin HC (2020) SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice. BMJ Open Gastroenterol 7(1):e000381. https:\/\/doi.org\/10.1136\/bmjgast-2020-000381","journal-title":"BMJ Open Gastroenterol"},{"issue":"22","key":"4069_CR173","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.21037\/atm-21-5043","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, Shao Y, Tu J, Sun J, Li L, Tao J, Chen J (2021) Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling. Annals Transl Med 9(22):1670","journal-title":"Annals Transl Med"},{"issue":"14","key":"4069_CR174","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/CM9.0000000000002277","volume":"135","author":"J Liu","year":"2022","unstructured":"Liu J, Tian Y, Fu X, Mu C, Yao M, Ni Y, Li Z (2022) Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis. Chin Med J 135(14):1682\u20131691. https:\/\/doi.org\/10.1097\/CM9.0000000000002277","journal-title":"Chin Med J"},{"issue":"2","key":"4069_CR175","doi-asserted-by":"publisher","first-page":"2255825","DOI":"10.1080\/07853890.2023.2255825","volume":"55","author":"L Liu","year":"2023","unstructured":"Liu L, Geng Y, Xiong C (2023) Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease. Ann Med 55(2):2255825. https:\/\/doi.org\/10.1080\/07853890.2023.2255825","journal-title":"Ann Med"},{"issue":"11","key":"4069_CR176","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/nutrit\/nuy03","volume":"76","author":"BR Loman","year":"2018","unstructured":"Loman BR, Hern\u00e1ndez-Saavedra D, An R, Rector RS (2018) Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev 76(11):822\u2013839. https:\/\/doi.org\/10.1093\/nutrit\/nuy03","journal-title":"Nutr Rev"},{"key":"4069_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.773340","volume":"12","author":"X Long","year":"2021","unstructured":"Long X, Liu D, Gao Q, Ni J, Qian L, Ni Y, Li H (2021) Bifidobacterium adolescentis alleviates liver steatosis and steatohepatitis by increasing fibroblast growth factor 21 sensitivity. Front Endocrinol 12:773340. https:\/\/doi.org\/10.3389\/fendo.2021.773340","journal-title":"Front Endocrinol"},{"issue":"5","key":"4069_CR178","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Nelson KE (2017) Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab 25(5):1054\u20131062. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.001","journal-title":"Cell Metab"},{"key":"4069_CR179","doi-asserted-by":"publisher","unstructured":"Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, GS\u2010US\u2010384\u20101497 Investigators (2018) The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology 67(2):549-559. https:\/\/doi.org\/10.1002\/hep.29514","DOI":"10.1002\/hep.29514"},{"issue":"1","key":"4069_CR180","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ (2017) Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19(1):29\u201341. https:\/\/doi.org\/10.1111\/1462-2920.13589","journal-title":"Environ Microbiol"},{"issue":"18","key":"4069_CR181","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.3390\/foods13182992","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Shataer D, Yan H, Dong X, Zhang M, Qin Y, Wang L (2024) Probiotics and non-alcoholic fatty liver disease: Unveiling the mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in modulating lipid metabolism, inflammation, and intestinal barrier integrity. Foods 13(18):2992. https:\/\/doi.org\/10.3390\/foods13182992","journal-title":"Foods"},{"key":"4069_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2020.01.163","volume":"52","author":"KJ Lucas","year":"2020","unstructured":"Lucas KJ, Lopez P, Lawitz E, Sheikh A, Aizenberg D, Hsia S, Sanyal A (2020) Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results. Dig Liver Dis 52:e38. https:\/\/doi.org\/10.1016\/j.dld.2020.01.163","journal-title":"Dig Liver Dis"},{"key":"4069_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.597648","volume":"11","author":"C Luci","year":"2020","unstructured":"Luci C, Bourinet M, Lecl\u00e8re PS, Anty R, Gual P (2020) Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies. Front Endocrinol 11:597648. https:\/\/doi.org\/10.3389\/fendo.2020.597648","journal-title":"Front Endocrinol"},{"issue":"1\u20132","key":"4069_CR184","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jneuroim.2004.06.008","volume":"155","author":"BT Lund","year":"2004","unstructured":"Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Weiner LP (2004) Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 155(1\u20132):161\u2013171. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.06.008","journal-title":"J Neuroimmunol"},{"issue":"5","key":"4069_CR185","first-page":"2668","volume":"11","author":"Y Luo","year":"2019","unstructured":"Luo Y, Tian G, Zhuang Z, Chen J, You N, Zhuo L, Shi J (2019) Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. Am J Transl Res 11(5):2668","journal-title":"Am J Transl Res"},{"issue":"6","key":"4069_CR186","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/nu15061355","volume":"15","author":"H Lv","year":"2023","unstructured":"Lv H, Tao F, Peng L, Chen S, Ren Z, Chen J, Wan C (2023) In vitro probiotic properties of Bifidobacterium animalis subsp. lactis SF and its alleviating effect on non-alcoholic fatty liver disease. Nutrients 15(6):1355. https:\/\/doi.org\/10.3390\/nu15061355","journal-title":"Nutrients"},{"issue":"6","key":"4069_CR187","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.3390\/ijms23063303","volume":"23","author":"A Lymperopoulos","year":"2022","unstructured":"Lymperopoulos A, Suster MS, Borges JI (2022) Short-chain fatty acid receptors and cardiovascular function. Int J Mol Sci 23(6):3303. https:\/\/doi.org\/10.3390\/ijms23063303","journal-title":"Int J Mol Sci"},{"issue":"40","key":"4069_CR188","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","volume":"19","author":"YY Ma","year":"2013","unstructured":"Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM (2013) Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol 19(40):6911. https:\/\/doi.org\/10.3748\/wjg.v19.i40.6911","journal-title":"World J Gastroenterol"},{"issue":"7593","key":"4069_CR189","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Greten TF (2016) NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531(7593):253\u2013257. https:\/\/doi.org\/10.1038\/nature16969","journal-title":"Nature"},{"issue":"2","key":"4069_CR190","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.2888","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Sun SH (2017a) METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing. Hepatology 65(2):529\u2013543. https:\/\/doi.org\/10.1002\/hep.2888","journal-title":"Hepatology"},{"issue":"10","key":"4069_CR191","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/nu9101124","volume":"9","author":"J Ma","year":"2017","unstructured":"Ma J, Zhou Q, Li H (2017b) Gut microbiota and nonalcoholic fatty liver disease: insights on mechanisms and therapy. Nutrients 9(10):1124. https:\/\/doi.org\/10.3390\/nu9101124","journal-title":"Nutrients"},{"issue":"6391","key":"4069_CR192","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Greten TF (2018) Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360(6391):eaan5931. https:\/\/doi.org\/10.1126\/science.aan5931","journal-title":"Science"},{"issue":"4","key":"4069_CR193","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/hep.31122","volume":"72","author":"L Ma","year":"2020","unstructured":"Ma L, Li H, Hu J, Zheng J, Zhou J, Botchlett R, Wu C (2020) Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-Phosphofructo-2-kinase\/Fructose-2, 6-Biphosphatase 3. Hepatology 72(4):1191\u20131203. https:\/\/doi.org\/10.1002\/hep.31122","journal-title":"Hepatology"},{"issue":"2","key":"4069_CR194","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/JLB.4RU0920-632R","volume":"109","author":"H Ma","year":"2021","unstructured":"Ma H, Qiu Y, Yang H (2021) Intestinal intraepithelial lymphocytes: Maintainers of intestinal immune tolerance and regulators of intestinal immunity. J Leukoc Biol 109(2):339\u2013347. https:\/\/doi.org\/10.1002\/JLB.4RU0920-632R","journal-title":"J Leukoc Biol"},{"issue":"3","key":"4069_CR195","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T (2018) Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology 155(3):629\u2013647. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.083","journal-title":"Gastroenterology"},{"key":"4069_CR196","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G (2020) Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 111:154170. https:\/\/doi.org\/10.1016\/j.metabol.2020.154170","journal-title":"Metabolism"},{"key":"4069_CR197","unstructured":"Marion SAM (2020) Biogeography and biochemistry of bile acid 7-dehydroxylation in the mammalian gut (No. 7350). EPFL"},{"issue":"3","key":"4069_CR198","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F (2014) Roles for chemokines in liver disease. Gastroenterology 147(3):577\u2013594. https:\/\/doi.org\/10.1053\/j.gastro.2014.06.043","journal-title":"Gastroenterology"},{"issue":"1","key":"4069_CR199","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12944-024-02231-9","volume":"23","author":"M Matboli","year":"2024","unstructured":"Matboli M, Abdelbaky I, Khaled A, Khaled R, Hamady S, Farid LM, Ali M (2024) Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model. Lipids Health Dis 23(1):266. https:\/\/doi.org\/10.1186\/s12944-024-02231-9","journal-title":"Lipids Health Dis"},{"key":"4069_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/fmb-2023-0123","volume":"19","author":"B Mbaye","year":"2024","unstructured":"Mbaye B, Wasfy RM, Alou MT, Borentain P, Gerolami R, Dufour JC, Million M (2024) A catalog of ethanol-producing microbes in humans. Fut Microbiol 19:1\u201318. https:\/\/doi.org\/10.2217\/fmb-2023-0123","journal-title":"Fut Microbiol"},{"issue":"8","key":"4069_CR201","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41577-018-0028-2","volume":"18","author":"BD McDonald","year":"2018","unstructured":"McDonald BD, Jabri B, Bendelac A (2018) Diverse developmental pathways of intestinal intraepithelial lymphocytes. Nat Rev Immunol 18(8):514\u2013525. https:\/\/doi.org\/10.1038\/s41577-018-0028-2","journal-title":"Nat Rev Immunol"},{"key":"4069_CR202","doi-asserted-by":"publisher","first-page":"0363","DOI":"10.34133\/2024\/10363","volume":"7","author":"G Miao","year":"2024","unstructured":"Miao G, Guo J, Zhang W, Lai P, Xu Y, Chen J, Xian X (2024) Remodeling intestinal microbiota alleviates severe combined hyperlipidemia-induced nonalcoholic steatohepatitis and atherosclerosis in LDLR-\/-Hamsters. Research 7:0363. https:\/\/doi.org\/10.34133\/2024\/10363","journal-title":"Research"},{"key":"4069_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105115","volume":"158","author":"R Mirzaei","year":"2021","unstructured":"Mirzaei R, Sholeh M, Jalalifar S, Zafari E, Kazemi S, Rasouli-Saravani A, Yousefimashouf R (2021) Immunometabolism in human brucellosis: an emerging field of investigation. Microb Pathog 158:105115. https:\/\/doi.org\/10.1016\/j.micpath.2021.105115","journal-title":"Microb Pathog"},{"issue":"23","key":"4069_CR204","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","volume":"20","author":"K Miura","year":"2014","unstructured":"Miura K, Ohnishi H (2014) Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol 20(23):7381\u20137391. https:\/\/doi.org\/10.3748\/wjg.v20.i23.7381","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4069_CR205","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hep.26081","volume":"57","author":"K Miura","year":"2013","unstructured":"Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57(2):577\u2013589. https:\/\/doi.org\/10.1002\/hep.26081","journal-title":"Hepatology"},{"issue":"7","key":"4069_CR206","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/1389450116666150317110040","volume":"16","author":"S Mohammad","year":"2015","unstructured":"Mohammad S (2015) Role of free fatty acid receptor 2 (FFAR2) in the regulation of metabolic homeostasis. Curr Drug Targets 16(7):771\u2013775. https:\/\/doi.org\/10.2174\/1389450116666150317110040","journal-title":"Curr Drug Targets"},{"key":"4069_CR207","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2021","unstructured":"Mohammad S, Thiemermann C (2021) Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 11:594150. https:\/\/doi.org\/10.3389\/fimmu.2020.594150","journal-title":"Front Immunol"},{"key":"4069_CR208","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1096\/fasebj.29.1_supplement.672.5","volume":"29","author":"S Mora","year":"2015","unstructured":"Mora S, Fullerton R (2015) Effects of short chain fatty acids on glucose and lipid metabolism in adipocytes. FASEB J 29:672\u2013675. https:\/\/doi.org\/10.1096\/fasebj.29.1_supplement.672.5","journal-title":"FASEB J"},{"key":"4069_CR209","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1096\/fasebj.30.1_supplement.691.20","volume":"30","author":"R Moreau","year":"2016","unstructured":"Moreau R, Erickson A, Bruner N, Xia M, He B (2016) Role of acetyl-CoA metabolizing enzyme ACSS2 and dietary acetyl-CoA precursors in transcription and lipid disorder. FASEB J 30:691\u2013720. https:\/\/doi.org\/10.1096\/fasebj.30.1_supplement.691.20","journal-title":"FASEB J"},{"issue":"5","key":"4069_CR210","doi-asserted-by":"publisher","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","volume":"11","author":"M Mouzaki","year":"2016","unstructured":"Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Allard JP (2016) Bile acids and dysbiosis in non-alcoholic fatty liver disease. PLoS ONE 11(5):e0151829. https:\/\/doi.org\/10.1371\/journal.pone.0151829","journal-title":"PLoS ONE"},{"key":"4069_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110240","volume":"143","author":"HN Mu","year":"2021","unstructured":"Mu HN, Zhou Q, Yang RY, Tang WQ, Li HX, Wang SM, Dong J (2021) Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Res Int 143:110240. https:\/\/doi.org\/10.1016\/j.foodres.2021.110240","journal-title":"Food Res Int"},{"key":"4069_CR212","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.vetimm.2016.10.001","volume":"182","author":"K Murakami","year":"2016","unstructured":"Murakami K, Maeda S, Yonezawa T, Matsuki N (2016) CC chemokine ligand 2 and CXC chemokine ligand 8 as neutrophil chemoattractant factors in canine idiopathic polyarthritis. Vet Immunol Immunopathol 182:52\u201358. https:\/\/doi.org\/10.1016\/j.vetimm.2016.10.001","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"4069_CR213","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12967-023-04120-0","volume":"21","author":"M Myint","year":"2023","unstructured":"Myint M, Oppedisano F, De Giorgi V, Kim BM, Marincola FM, Alter HJ, Nesci S (2023) Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. J Transl Med 21(1):757. https:\/\/doi.org\/10.1186\/s12967-023-04120-0","journal-title":"J Transl Med"},{"issue":"1","key":"4069_CR214","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41598-024-29456-7","volume":"14","author":"AR Naderi Yaghouti","year":"2024","unstructured":"Naderi Yaghouti AR, Zamanian H, Shalbaf A (2024a) Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters. Sci Rep 14(1):2442. https:\/\/doi.org\/10.1038\/s41598-024-29456-7","journal-title":"Sci Rep"},{"issue":"1","key":"4069_CR215","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41598-024-51741-0","volume":"14","author":"AR Naderi Yaghouti","year":"2024","unstructured":"Naderi Yaghouti AR, Zamanian H, Shalbaf A (2024b) Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters. Sci Rep 14(1):2442. https:\/\/doi.org\/10.1038\/s41598-024-51741-0","journal-title":"Sci Rep"},{"issue":"15","key":"4069_CR216","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.3390\/ijms22158008","volume":"22","author":"M Nagashimada","year":"2021","unstructured":"Nagashimada M, Honda M (2021) Effect of microbiome on non-alcoholic fatty liver disease and the role of probiotics, prebiotics, and biogenics. Int J Mol Sci 22(15):8008. https:\/\/doi.org\/10.3390\/ijms22158008","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4069_CR217","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/1573399815666191001104910","volume":"16","author":"SS Nawaz","year":"2020","unstructured":"Nawaz SS, Siddiqui K (2020) The emerging role of branch chain amino acids in the prediction of diabetes: a brief review. Curr Diabetes Rev 16(6):532\u2013537. https:\/\/doi.org\/10.2174\/1573399815666191001104910","journal-title":"Curr Diabetes Rev"},{"issue":"4","key":"4069_CR218","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1615\/CritRevImmunol.2021039490","volume":"41","author":"A Nazmi","year":"2021","unstructured":"Nazmi A, McClanahan KG, Olivares-Villagomez D (2021) Unconventional intestinal intraepithelial lymphocytes in health and disease. Critic RevTM Immunol 41(4):341\u2013354. https:\/\/doi.org\/10.1615\/CritRevImmunol.2021039490","journal-title":"Critic RevTM Immunol"},{"issue":"2","key":"4069_CR219","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.020","volume":"73","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Palmer M, Freilich B, Sheikh MY, Sheikh A, Sarles H, Volixibat in Adults study group. (2020) Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study. J Hepatol 73(2):231\u2013240. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.020","journal-title":"J Hepatol"},{"issue":"1","key":"4069_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","volume":"8","author":"TLA Nguyen","year":"2015","unstructured":"Nguyen TLA, Vieira-Silva S, Liston A, Raes J (2015) How informative is the mouse for human gut microbiota research? Dis Model Mech 8(1):1\u201316. https:\/\/doi.org\/10.1242\/dmm.017400","journal-title":"Dis Model Mech"},{"issue":"17","key":"4069_CR221","doi-asserted-by":"publisher","first-page":"2000375","DOI":"10.1002\/mnfr.202000375","volume":"64","author":"Y Ni","year":"2020","unstructured":"Ni Y, Ni L, Zhuge F, Fu Z (2020) The gut microbiota and its metabolites, novel targets for treating and preventing non-alcoholic fatty liver disease. Mol Nutr Food Res 64(17):2000375. https:\/\/doi.org\/10.1002\/mnfr.202000375","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"4069_CR222","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie C, He T, Zhang W, Zhang G, Ma X (2018) Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci 19(4):954. https:\/\/doi.org\/10.3390\/ijms19040954","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4069_CR223","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.coi.2012.07.002","volume":"24","author":"KM Nutsch","year":"2012","unstructured":"Nutsch KM, Hsieh CS (2012) T cell tolerance and immunity to commensal bacteria. Curr Opin Immunol 24(4):385\u2013391. https:\/\/doi.org\/10.1016\/j.coi.2012.07.002","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"4069_CR224","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/brv","volume":"95","author":"DK Ocansey","year":"2020","unstructured":"Ocansey DK, Zhang L, Wang Y, Yan Y, Qian H, Zhang X, Mao F, Xu W (2020) Exosome-mediated effects and applications in inflammatory bowel disease. Biol Rev 95(5):1287\u20131307. https:\/\/doi.org\/10.1111\/brv","journal-title":"Biol Rev"},{"issue":"9","key":"4069_CR225","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.3390\/ijms24097791","volume":"24","author":"A Odriozola","year":"2023","unstructured":"Odriozola A, Santos-Laso A, Del Barrio M, Cabezas J, Iruzubieta P, Arias-Loste MT, Crespo J (2023) Fatty liver disease, metabolism and alcohol interplay: a comprehensive review. Int J Mol Sci 24(9):7791. https:\/\/doi.org\/10.3390\/ijms24097791","journal-title":"Int J Mol Sci"},{"key":"4069_CR226","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/nu12051435","volume":"12","author":"F Oppedisano","year":"2020","unstructured":"Oppedisano F (2020) The protective effect of cynara cardunculus extract in diet-induced NAFLD: involvement of OCTN1 and OCTN2 transporter subfamily. Nutrients 12:1435","journal-title":"Nutrients"},{"issue":"6","key":"4069_CR227","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","volume":"65","author":"LA Ormandy","year":"2005","unstructured":"Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Can Res 65(6):2457\u20132464. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3232","journal-title":"Can Res"},{"key":"4069_CR228","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40268-014-0068-2","volume":"14","author":"P Pais","year":"2014","unstructured":"Pais P, D\u2019Amato M (2014) In vivo efficacy study of milk thistle extract (ETHIS-094\u2122) in STAM\u2122 model of nonalcoholic steatohepatitis. Drugs R&D 14:291\u2013299. https:\/\/doi.org\/10.1007\/s40268-014-0068-2","journal-title":"Drugs R&D"},{"issue":"2","key":"4069_CR229","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/nu12020542","volume":"12","author":"EJ Park","year":"2020","unstructured":"Park EJ, Lee YS, Kim SM, Park GS, Lee YH, Jeong DY, Lee HJ (2020) Beneficial effects of Lactobacillus plantarum strains on non-alcoholic fatty liver disease in high fat\/high fructose diet-fed rats. Nutrients 12(2):542. https:\/\/doi.org\/10.3390\/nu12020542","journal-title":"Nutrients"},{"issue":"1","key":"4069_CR230","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/ijms23010426","volume":"23","author":"JW Park","year":"2021","unstructured":"Park JW, Kim SE, Lee NY, Kim JH, Jung JH, Jang MK, Suk KT (2021) Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases. Int J Mol Sci 23(1):426. https:\/\/doi.org\/10.3390\/ijms23010426","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4069_CR231","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"R Parker","year":"2018","unstructured":"Parker R, Kim SJ, Gao B (2018) Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol 15(1):50\u201359. https:\/\/doi.org\/10.1038\/nrgastro.2017.119","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4069_CR232","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/gmic.19246","volume":"3","author":"JA Parnell","year":"2012","unstructured":"Parnell JA, Reimer RA (2012) Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 3(1):29\u201334. https:\/\/doi.org\/10.4161\/gmic.19246","journal-title":"Gut Microbes"},{"issue":"4","key":"4069_CR233","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","volume":"4","author":"G Parthasarathy","year":"2020","unstructured":"Parthasarathy G, Revelo X, Malhi H (2020) Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun 4(4):478\u2013492. https:\/\/doi.org\/10.1002\/hep4.1479","journal-title":"Hepatol Commun"},{"issue":"7","key":"4069_CR234","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI1561","volume":"101","author":"ME Patti","year":"1998","unstructured":"Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR (1998) Bidirectional modulation of insulin action by amino acids. J Clin Investig 101(7):1519\u20131529. https:\/\/doi.org\/10.1172\/JCI1561","journal-title":"J Clin Investig"},{"issue":"10","key":"4069_CR235","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.P085340","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng KY, Watt MJ, Rensen S, Greve JW, Huynh K, Jayawardana KS, Meex RC (2018) Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J Lipid Res 59(10):1977\u20131986. https:\/\/doi.org\/10.1194\/jlr.P085340","journal-title":"J Lipid Res"},{"issue":"33","key":"4069_CR236","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.3748\/wjg.v11.i33.5185","volume":"11","author":"L Per\u00e1n","year":"2005","unstructured":"Per\u00e1n L, Camuesco D, Comalada M, Nieto A, Concha AC, D\u00edaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A, G\u00e1lvez J (2005) Preventative effects of a probiotic, Lactobacillus salivarius ssp salivarius, in the TNBS model of rat colitis. World J Gastroenterol 11(33):5185\u20135192. https:\/\/doi.org\/10.3748\/wjg.v11.i33.5185","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4069_CR237","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/diseases7010027","volume":"7","author":"BJ Perumpail","year":"2019","unstructured":"Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Ahmed A (2019) The therapeutic implications of the gut microbiome and probiotics in patients with NAFLD. Diseases 7(1):27. https:\/\/doi.org\/10.3390\/diseases7010027","journal-title":"Diseases"},{"issue":"5","key":"4069_CR238","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/medicina58050641","volume":"58","author":"M Petrescu","year":"2022","unstructured":"Petrescu M, Vlaicu SI, Cium\u0103rnean L, Milaciu MV, M\u0103rginean C, Florea M, Popa M (2022) Chronic inflammation\u2014A link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue. Medicina 58(5):641. https:\/\/doi.org\/10.3390\/medicina58050641","journal-title":"Medicina"},{"key":"4069_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106170","volume":"98","author":"B Pierre","year":"2020","unstructured":"Pierre B, Elisabetta B, Vlad R, Philippe HM, Bruno S, Jean-Louis J, Jean-Louis A (2020) A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study. Contemp Clin Trials 98:106170. https:\/\/doi.org\/10.1016\/j.cct.2020.106170","journal-title":"Contemp Clin Trials"},{"issue":"21","key":"4069_CR240","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.3390\/ijms21218351","volume":"21","author":"J Plaza-D\u00edaz","year":"2020","unstructured":"Plaza-D\u00edaz J, Sol\u00eds-Urra P, Rodr\u00edguez-Rodr\u00edguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abad\u00eda-Molina F, \u00c1lvarez-Mercado AI (2020) The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage. Int J Mol Sci 21(21):8351. https:\/\/doi.org\/10.3390\/ijms21218351","journal-title":"Int J Mol Sci"},{"issue":"06","key":"4069_CR241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36648\/2386-5180.8.6.335","volume":"8","author":"A Polampelli","year":"2020","unstructured":"Polampelli A (2020) Structure and Function of the Immune System. Annals Clin Lab Res 8(06):1\u201311. https:\/\/doi.org\/10.36648\/2386-5180.8.6.335","journal-title":"Annals Clin Lab Res"},{"issue":"6","key":"4069_CR242","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.05.003","volume":"14","author":"TW Pols","year":"2011","unstructured":"Pols TW, Nomura M, Harach T, Sasso GL, Oosterveer MH, Thomas C, Schoonjans K (2011) TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14(6):747\u2013757. https:\/\/doi.org\/10.1016\/j.cmet.2011.05.003","journal-title":"Cell Metab"},{"issue":"1","key":"4069_CR243","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, Mazzaferro V (2019) Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69(1):107\u2013120. https:\/\/doi.org\/10.1002\/hep.30036","journal-title":"Hepatology"},{"key":"4069_CR244","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","volume":"9","author":"D Porras","year":"2018","unstructured":"Porras D, Nistal E, Mart\u00ednez-Fl\u00f3rez S, Gonz\u00e1lez-Gallego J, Garc\u00eda-Mediavilla MV, S\u00e1nchez-Campos S (2018) Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease. Front Physiol 9:1813. https:\/\/doi.org\/10.3389\/fphys.2018.01813","journal-title":"Front Physiol"},{"issue":"8","key":"4069_CR245","doi-asserted-by":"publisher","first-page":"1800930","DOI":"10.1002\/mnfr.201800930","volume":"63","author":"D Porras","year":"2019","unstructured":"Porras D, Nistal E, Mart\u00ednez-Fl\u00f3rez S, Olcoz JL, Jover R, Jorquera F, S\u00e1nchez-Campos S (2019) Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in germ-free mice. Mol Nutr Food Res 63(8):1800930. https:\/\/doi.org\/10.1002\/mnfr.201800930","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"4069_CR246","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2174\/1573401319666230913122317","volume":"20","author":"P Prabhakar","year":"2023","unstructured":"Prabhakar P, Marakala V, Sacheendran D, George T, D\u2019souza RK, Palatty PL, Baliga MS (2023) Ginger (Zingiber officinale Roscoe; family: Zingiberaceae) in Non-Alcoholic Fatty Liver Disease: Review on the existing scientific evidence and way forward. Curr Nutr Food Sci 20(7):789\u2013796. https:\/\/doi.org\/10.2174\/1573401319666230913122317","journal-title":"Curr Nutr Food Sci"},{"issue":"1","key":"4069_CR247","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3920\/BM2023.0078","volume":"15","author":"P Prukpitikul","year":"2024","unstructured":"Prukpitikul P, Sirivarasai J, Sutjarit N (2024) The molecular mechanisms underlying gut microbiota-miRNA interaction in metabolic disorders. Beneficial Microbes 15(1):83\u201396. https:\/\/doi.org\/10.3920\/BM2023.0078","journal-title":"Beneficial Microbes"},{"issue":"2","key":"4069_CR248","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29449","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, Sanyal AJ (2018) The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology 67(2):534\u2013548. https:\/\/doi.org\/10.1002\/hep.29449","journal-title":"Hepatology"},{"issue":"1","key":"4069_CR249","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.pmbts.2022.01.001","volume":"191","author":"A Purohit","year":"2022","unstructured":"Purohit A, Alam MJ, Kandiyal B, Das B, Banerjee SK (2022) Gut microbiome and non-alcoholic fatty liver disease. Prog Mol Biol Transl Sci 191(1):187\u2013206. https:\/\/doi.org\/10.1016\/bs.pmbts.2022.01.001","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4069_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43440-019-00007-0","volume":"72","author":"N Pydyn","year":"2020","unstructured":"Pydyn N, Mi\u0119kus K, Jura J, Kotlinowski J (2020) New therapeutic strategies in nonalcoholic fatty liver disease: A focus on promising drugs for nonalcoholic steatohepatitis. Pharmacol Rep 72:1\u201312. https:\/\/doi.org\/10.1007\/s43440-019-00007-0","journal-title":"Pharmacol Rep"},{"issue":"2","key":"4069_CR251","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3892\/etm.2019.8384","volume":"19","author":"XY Qin","year":"2020","unstructured":"Qin XY, Su T, Kojima S (2020) Prevention of arachidonic acid-induced liver injury by controlling oxidative stress-mediated transglutaminase activation with garlic extracts. Exp Ther Med 19(2):1522\u20131527. https:\/\/doi.org\/10.3892\/etm.2019.8384","journal-title":"Exp Ther Med"},{"issue":"S1","key":"4069_CR252","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli V, Rehermann B (2006) The liver as an immunological organ. Hepatology 43(S1):S54\u2013S62. https:\/\/doi.org\/10.1002\/hep.21060","journal-title":"Hepatology"},{"issue":"13","key":"4069_CR253","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.3390\/ijms23137280","volume":"23","author":"R Ramanathan","year":"2022","unstructured":"Ramanathan R, Ali AH, Ibdah JA (2022) Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int J Mol Sci 23(13):7280. https:\/\/doi.org\/10.3390\/ijms23137280","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4069_CR254","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bjp.0704920","volume":"137","author":"GM Raso","year":"2002","unstructured":"Raso GM, Pacilio M, Esposito E, Coppola A, Di Carlo R, Meli R (2002) Leptin potentiates IFN-\u03b3-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1. Br J Pharmacol 137(6):799\u2013804. https:\/\/doi.org\/10.1038\/sj.bjp.0704920","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4069_CR255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18388\/abp.2018_2648","volume":"66","author":"W Ratajczak","year":"2019","unstructured":"Ratajczak W, Ry\u0142 A, Mizerski A, Walczakiewicz K, Sipak O, Laszczy\u0144ska M (2019) Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs). Acta Biochimica Polonica 66(1):1\u201312. https:\/\/doi.org\/10.18388\/abp.2018_2648","journal-title":"Acta Biochimica Polonica"},{"issue":"5","key":"4069_CR256","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","volume":"150","author":"V Ratziu","year":"2016","unstructured":"Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Gallegos-Orozco J (2016) Elafibranor, an agonist of the peroxisome proliferator\u2212activated receptor\u2212\u03b1 and\u2212\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology 150(5):1147\u20131159. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.038","journal-title":"Gastroenterology"},{"issue":"10","key":"4069_CR257","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618805216","volume":"6","author":"M Rau","year":"2018","unstructured":"Rau M, Rehman A, Dittrich M, Groen AK, Hermanns HM, Seyfried F, Geier A (2018) Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United Eur Gastroenterol J 6(10):1496\u20131507. https:\/\/doi.org\/10.1177\/2050640618805216","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"4069_CR258","doi-asserted-by":"publisher","first-page":"dev171520","DOI":"10.1242\/dev.171520","volume":"146","author":"AR Reedy","year":"2019","unstructured":"Reedy AR, Luo L, Neish AS, Jones RM (2019) Commensal microbiota-induced redox signaling activates proliferative signals in the intestinal stem cell microenvironment. Development 146(3):dev171520. https:\/\/doi.org\/10.1242\/dev.171520","journal-title":"Development"},{"issue":"6","key":"4069_CR259","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2014.14","volume":"8","author":"N Reichardt","year":"2014","unstructured":"Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, Louis P (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8(6):1323\u20131335. https:\/\/doi.org\/10.1038\/ismej.2014.14","journal-title":"ISME J"},{"issue":"3","key":"4069_CR260","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","volume":"53","author":"A Remmerie","year":"2020","unstructured":"Remmerie A, Martens L, Thon\u00e9 T, Castoldi A, Seurinck R, Pavie B, Scott CL (2020) Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity 53(3):641\u2013657. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.004","journal-title":"Immunity"},{"issue":"2","key":"4069_CR261","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/antiox10020270","volume":"10","author":"L Rinaldi","year":"2021","unstructured":"Rinaldi L, Pafundi PC, Galiero R, Caturano A, Morone MV, Silvestri C, Sasso FC (2021) Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A Narrat Rev Antioxid 10(2):270. https:\/\/doi.org\/10.3390\/antiox10020270","journal-title":"A Narrat Rev Antioxid"},{"issue":"4","key":"4069_CR262","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jhep.2018.12.027","volume":"70","author":"ME Rinella","year":"2019","unstructured":"Rinella ME, Trotter JF, Abdelmalek MF, Paredes AH, Connelly MA, Jaros MJ, Harrison SA (2019) Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis. J Hepatol 70(4):735\u2013744. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.027","journal-title":"J Hepatol"},{"issue":"1","key":"4069_CR263","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13510002.2019.1578870","volume":"24","author":"WA R\u00edos-Ocampo","year":"2019","unstructured":"R\u00edos-Ocampo WA, Daemen T, Buist-Homan M, Faber KN, Navas MC, Moshage H (2019) Hepatitis C virus core or NS3\/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress. Redox Rep 24(1):17\u201326. https:\/\/doi.org\/10.1080\/13510002.2019.1578870","journal-title":"Redox Rep"},{"issue":"5","key":"4069_CR264","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/1389201024666230216120210","volume":"24","author":"A Rodr\u00edguez-Past\u00e9n","year":"2023","unstructured":"Rodr\u00edguez-Past\u00e9n A, Fern\u00e1ndez-Mart\u00ednez E, P\u00e9rez-Hern\u00e1ndez N, Soria-Jasso LE, Cario-Cort\u00e9s R (2023) Prebiotics and probiotics: effects on dyslipidemia and NAFLD\/NASH and the associated mechanisms of action. Curr Pharm Biotechnol 24(5):633\u2013646. https:\/\/doi.org\/10.2174\/1389201024666230216120210","journal-title":"Curr Pharm Biotechnol"},{"key":"4069_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102313","volume":"52","author":"O Rom","year":"2022","unstructured":"Rom O, Liu Y, Finney AC, Ghrayeb A, Zhao Y, Shukha Y, Chen YE (2022) Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis. Redox Biol 52:102313. https:\/\/doi.org\/10.1016\/j.redox.2022.102313","journal-title":"Redox Biol"},{"issue":"2","key":"4069_CR266","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","volume":"6","author":"KA Romano","year":"2015","unstructured":"Romano KA, Vivas EI, Amador-Noguez D, Rey FE (2015) Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio 6(2):e02481\u2013e024814. https:\/\/doi.org\/10.1128\/mBio.02481-14","journal-title":"mBio"},{"issue":"5","key":"4069_CR267","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cmet.2020.04.001","volume":"31","author":"BJ Saeedi","year":"2020","unstructured":"Saeedi BJ, Liu KH, Owens JA, Hunter-Chang S, Camacho MC, Eboka RU, Neish AS (2020) Gut-resident lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury. Cell Metab 31(5):956\u2013968. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.001","journal-title":"Cell Metab"},{"key":"4069_CR268","unstructured":"Saeedi BJ (2020) Gut-Resident Microbes Modulate Hepatic Metabolism and Susceptibility to Disease (Doctoral dissertation, Emory University)"},{"key":"4069_CR269","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphys.2012.00213","volume":"3","author":"Y Saiman","year":"2012","unstructured":"Saiman Y, Friedman SL (2012) The role of chemokines in acute liver injury. Front Physiol 3:213. https:\/\/doi.org\/10.3389\/fphys.2012.00213","journal-title":"Front Physiol"},{"issue":"6","key":"4069_CR270","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218459","volume":"14","author":"K Salic","year":"2019","unstructured":"Salic K, Kleemann R, Wilkins-Port C, McNulty J, Verschuren L, Palmer M (2019) Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-\/-. Leiden Mice PLOS ONE 14(6):e0218459. https:\/\/doi.org\/10.1371\/journal.pone.0218459","journal-title":"Leiden Mice PLOS ONE"},{"issue":"2","key":"4069_CR271","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117178","volume":"10","author":"M Samad","year":"2015","unstructured":"Samad M, Chung AJ, Shams L (2015) Perception of body ownership is driven by Bayesian sensory inference. PLoS ONE 10(2):e0117178. https:\/\/doi.org\/10.1371\/journal.pone.0117178","journal-title":"PLoS ONE"},{"key":"4069_CR272","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DMSO.S146339","volume":"11","author":"R Sarwar","year":"2018","unstructured":"Sarwar R, Pierce N, Koppe S (2018) Obesity and nonalcoholic fatty liver disease: current perspectives. Diab Metab Syndr Obes Targets Ther 11:533\u2013542. https:\/\/doi.org\/10.2147\/DMSO.S146339","journal-title":"Diab Metab Syndr Obes Targets Ther"},{"issue":"2","key":"4069_CR273","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1152\/ajpendo.00420.2020","volume":"320","author":"JD Schertzer","year":"2021","unstructured":"Schertzer JD, Lam TK (2021) Peripheral and central regulation of insulin by the intestine and microbiome. Am J Physio lEndocrinol Metab 320(2):E234\u2013E239. https:\/\/doi.org\/10.1152\/ajpendo.00420.2020","journal-title":"Am J Physio lEndocrinol Metab"},{"issue":"3","key":"4069_CR274","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","volume":"30","author":"BD Semple","year":"2010","unstructured":"Semple BD, Kossmann T, Morganti-Kossmann MC (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks. J Cereb Blood Flow Metab 30(3):459\u2013473. https:\/\/doi.org\/10.1038\/jcbfm.2009.240","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"4069_CR275","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jmb.2018.01.006","volume":"430","author":"M Serino","year":"2018","unstructured":"Serino M (2018) Molecular paths linking metabolic diseases, gut microbiota dysbiosis and enterobacteria infections. J Mol Biol 430(5):581\u2013590. https:\/\/doi.org\/10.1016\/j.jmb.2018.01.006","journal-title":"J Mol Biol"},{"issue":"5","key":"4069_CR276","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/17474124.2020.1750360","volume":"14","author":"RA Shah","year":"2020","unstructured":"Shah RA, Kowdley KV (2020) Obeticholic acid for the treatment of nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 14(5):311\u2013321. https:\/\/doi.org\/10.1080\/17474124.2020.1750360","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"4069_CR277","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2020.10.007","volume":"33","author":"SR Sharpton","year":"2021","unstructured":"Sharpton SR, Schnabl B, Knight R, Loomba R (2021) Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease. Cell Metab 33(1):21\u201332. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.007","journal-title":"Cell Metab"},{"issue":"6","key":"4069_CR278","doi-asserted-by":"publisher","first-page":"375","DOI":"10.18786\/2072-0505-2020-48-066","volume":"48","author":"ES Shcherbakova","year":"2020","unstructured":"Shcherbakova ES, Sall TS, Sitkin SI, Vakhitov TY, Demyanova EV (2020) The role of bacterial metabolites derived from aromatic amino acids in non-alcoholic fatty liver disease. Alman Clin Med 48(6):375\u2013386","journal-title":"Alman Clin Med"},{"key":"4069_CR279","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bcp.2018.01.034","volume":"150","author":"L Shi","year":"2018","unstructured":"Shi L, Hao Z, Zhang S, Wei M, Lu B, Wang Z, Ji L (2018) Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1\/2 and PKC. Biochem Pharmacol 150:9\u201323. https:\/\/doi.org\/10.1016\/j.bcp.2018.01.034","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4069_CR280","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15030","volume":"49","author":"M Shiffman","year":"2019","unstructured":"Shiffman M, Freilich B, Vuppalanchi R, Watt K, Chan JL, Spada A, Schiff E (2019) Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3\/7 activation in subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 49(1):64\u201373. https:\/\/doi.org\/10.1111\/apt.15030","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"4069_CR281","doi-asserted-by":"publisher","first-page":"e80604","DOI":"10.1371\/journal.pone.0080604","volume":"8","author":"Y Shimada","year":"2013","unstructured":"Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H, Takeda K (2013) Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS ONE 8(11):e80604. https:\/\/doi.org\/10.1371\/journal.pone.0080604","journal-title":"PLoS ONE"},{"issue":"6","key":"4069_CR282","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/13813455.2023.2243651","volume":"130","author":"H Singh","year":"2024","unstructured":"Singh H, Singh R, Singh A, Singh H, Singh G, Kaur S, Singh B (2024) Role of oxidative stress in diabetes-induced complications and their management with antioxidants. Arch Physiol Biochem 130(6):616\u2013641","journal-title":"Arch Physiol Biochem"},{"key":"4069_CR283","doi-asserted-by":"publisher","first-page":"6175804","DOI":"10.1155\/2019\/6175804","volume":"2019","author":"AV Snezhkina","year":"2019","unstructured":"Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA (2019) ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev 2019:6175804. https:\/\/doi.org\/10.1155\/2019\/6175804","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4069_CR284","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines10030524","volume":"10","author":"Q Song","year":"2022","unstructured":"Song Q, Zhang X (2022) The role of gut\u2013liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines 10(3):524. https:\/\/doi.org\/10.3390\/biomedicines10030524","journal-title":"Biomedicines"},{"issue":"10","key":"4069_CR285","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/nu10101383","volume":"10","author":"Z Song","year":"2018","unstructured":"Song Z, Xiaoli AM, Yang F (2018) Regulation and metabolic significance of de novo lipogenesis in adipose tissues. Nutrients 10(10):1383. https:\/\/doi.org\/10.3390\/nu10101383","journal-title":"Nutrients"},{"issue":"3","key":"4069_CR286","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/10409231003667500","volume":"45","author":"MS Strable","year":"2010","unstructured":"Strable MS, Ntambi JM (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 45(3):199\u2013214. https:\/\/doi.org\/10.3109\/10409231003667500","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"4069_CR287","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17474124.2019.1572570","volume":"13","author":"KT Suk","year":"2019","unstructured":"Suk KT, Kim DJ (2019) Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 13(3):193\u2013204. https:\/\/doi.org\/10.1080\/17474124.2019.1572570","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4069_CR288","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol 53:362\u2013376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1","journal-title":"J Gastroenterol"},{"key":"4069_CR289","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fbioe.2020.00833","volume":"8","author":"S Sun","year":"2020","unstructured":"Sun S, Ding Y, Liu M, Xian M, Zhao G (2020) Comparison of glucose, acetate and ethanol as carbon resource for production of poly(3-hydroxybutyrate) and other acetyl-CoA derivatives. Front Bioeng Biotechnol 8:833. https:\/\/doi.org\/10.3389\/fbioe.2020.00833","journal-title":"Front Bioeng Biotechnol"},{"key":"4069_CR290","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.04.027","volume":"144","author":"G Svegliati-Baroni","year":"2019","unstructured":"Svegliati-Baroni G, Pierantonelli I, Torquato P, Marinelli R, Ferreri C, Chatgilialoglu C, Galli F (2019) Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Rad Biol Med 144:293\u2013309. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.04.027","journal-title":"Free Rad Biol Med"},{"key":"4069_CR291","doi-asserted-by":"publisher","first-page":"1337945","DOI":"10.3389\/frlct.2023.1337945","volume":"2","author":"S Taavitsainen","year":"2024","unstructured":"Taavitsainen S, Juuti-Uusitalo K, Kurppa K, Lindfors K, Kallio P, Kellom\u00e4ki M (2024) Gut-on-chip devices as intestinal inflammation models and their future for studying multifactorial diseases. Front Lab On Chip Technol 2:1337945. https:\/\/doi.org\/10.3389\/frlct.2023.1337945","journal-title":"Front Lab On Chip Technol"},{"issue":"3","key":"4069_CR292","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13543784.2018.1442413","volume":"27","author":"F Tacke","year":"2018","unstructured":"Tacke F (2018) Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis. Expert Opin Investig Drugs 27(3):301\u2013311. https:\/\/doi.org\/10.1080\/13543784.2018.1442413","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"4069_CR293","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW (2014) Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60(5):1090\u20131096. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.025","journal-title":"J Hepatol"},{"issue":"13","key":"4069_CR294","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","volume":"21","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, Sugimoto K, Inui H, Fukusato T (2015) Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol: WJG 21(13):3777. https:\/\/doi.org\/10.3748\/wjg.v21.i13.3777","journal-title":"World J Gastroenterol: WJG"},{"issue":"7978","key":"4069_CR295","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-023-06420-8","volume":"621","author":"T Takeuchi","year":"2023","unstructured":"Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon ATJ, Ohno H (2023) Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature 621(7978):389\u2013395. https:\/\/doi.org\/10.1038\/s41586-023-06420-8","journal-title":"Nature"},{"issue":"17","key":"4069_CR296","doi-asserted-by":"publisher","first-page":"1900257","DOI":"10.1002\/mnfr.201900257","volume":"63","author":"X Tan","year":"2019","unstructured":"Tan X, Liu Y, Long J, Chen S, Liao G, Wu S, Zhu H (2019) Trimethylamine N-oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease. Mol Nutr Food Res 63(17):1900257. https:\/\/doi.org\/10.1002\/mnfr.201900257","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"4069_CR297","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4254\/wjh.v12.i7.332","volume":"12","author":"HK Tan","year":"2020","unstructured":"Tan HK, Yates E, Lilly K, Dhanda AD (2020) Oxidative stress in alcohol-related liver disease. World J Hepatol 12(7):332. https:\/\/doi.org\/10.4254\/wjh.v12.i7.332","journal-title":"World J Hepatol"},{"issue":"3","key":"4069_CR298","doi-asserted-by":"publisher","first-page":"099","DOI":"10.2492\/inflammregen.35.099","volume":"35","author":"T Tanoue","year":"2015","unstructured":"Tanoue T, Honda K (2015) Regulation of intestinal Th17 and Treg cells by gut microbiota. Inflamm Regen 35(3):099\u2013105. https:\/\/doi.org\/10.2492\/inflammregen.35.099","journal-title":"Inflamm Regen"},{"issue":"5","key":"4069_CR299","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/gutjnl-2020-321534","volume":"70","author":"VR Thangapandi","year":"2021","unstructured":"Thangapandi VR, Knittelfelder O, Brosch M, Patsenker E, Vvedenskaya O, Buch S, Subramanian P (2021) Loss of hepatic Mboat7 leads to liver fibrosis. Gut 70(5):940\u2013950. https:\/\/doi.org\/10.1136\/gutjnl-2020-321534","journal-title":"Gut"},{"issue":"12","key":"4069_CR300","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/metabo12121243","volume":"12","author":"P Theofilis","year":"2022","unstructured":"Theofilis P, Vordoni A, Kalaitzidis RG (2022) Trimethylamine N-oxide levels in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolites 12(12):1243. https:\/\/doi.org\/10.3390\/metabo12121243","journal-title":"Metabolites"},{"issue":"6","key":"4069_CR301","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jgr.2022.03.001","volume":"46","author":"F Tian","year":"2022","unstructured":"Tian F, Huang S, Xu W, Chen L, Su J, Ni H, Huang Q (2022) Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism. J Ginseng Res 46(6):780\u2013789. https:\/\/doi.org\/10.1016\/j.jgr.2022.03.001","journal-title":"J Ginseng Res"},{"key":"4069_CR302","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-017-0736-0","volume":"18","author":"RG Tiessen","year":"2018","unstructured":"Tiessen RG, Kennedy CA, Keller BT, Levin N, Acevedo L, Gedulin B, Palmer M (2018) Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. BMC Gastroenterol 18:1\u201317. https:\/\/doi.org\/10.1186\/s12876-017-0736-0","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4069_CR303","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.712","volume":"9","author":"P Tipthara","year":"2021","unstructured":"Tipthara P, Kobylinski KC, Godejohann M, Hanboonkunupakarn B, Roth A, Adams JH, Tarning J (2021) Identification of the metabolites of ivermectin in humans. Pharmacol Res Perspect 9(1):e00712. https:\/\/doi.org\/10.1002\/prp2.712","journal-title":"Pharmacol Res Perspect"},{"issue":"48","key":"4069_CR304","doi-asserted-by":"publisher","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","volume":"287","author":"AC Tosello-Trampont","year":"2012","unstructured":"Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS (2012) Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-\u03b1 production. J Biol Chem 287(48):40161\u201340172. https:\/\/doi.org\/10.1074\/jbc.M112.417014","journal-title":"J Biol Chem"},{"issue":"4","key":"4069_CR305","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/01.mco.0000172574.96438.35","volume":"8","author":"F Tremblay","year":"2005","unstructured":"Tremblay F, Jacques H, Marette A (2005) Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway. Curr Opin Clin Nutr Metab Care 8(4):457\u2013462. https:\/\/doi.org\/10.1097\/01.mco.0000172574.96438.35","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"24","key":"4069_CR306","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1021\/acs.jmedchem.7b00907","volume":"60","author":"DC Tully","year":"2017","unstructured":"Tully DC, Rucker PV, Chianelli D, Williams J, Vidal A, Alper PB, Laffitte B (2017) Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH). J Med Chem 60(24):9960\u20139973. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00907","journal-title":"J Med Chem"},{"key":"4069_CR307","doi-asserted-by":"publisher","first-page":"61427","DOI":"10.1039\/C4RA11280A","volume":"4","author":"TF Tzeng","year":"2014","unstructured":"Tzeng TF, Liou SS, Liu IM (2014) 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation, and fibrogenesis. RSC Adv 4:61427\u201361436. https:\/\/doi.org\/10.1039\/C4RA11280A","journal-title":"RSC Adv"},{"issue":"1","key":"4069_CR308","doi-asserted-by":"publisher","first-page":"e220271","DOI":"10.1530\/JOE-22-0271","volume":"257","author":"M van de Vyver","year":"2023","unstructured":"van de Vyver M (2023) Immunology of chronic low-grade inflammation: relationship with metabolic function. J Endocrinol 257(1):e220271. https:\/\/doi.org\/10.1530\/JOE-22-0271","journal-title":"J Endocrinol"},{"issue":"2","key":"4069_CR309","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4049\/jimmunol.2200270","volume":"209","author":"L Van Kaer","year":"2022","unstructured":"Van Kaer L, Postoak JL, Song W, Wu L (2022) Innate and innate-like effector lymphocytes in health and disease. J Immunol 209(2):199\u2013207. https:\/\/doi.org\/10.4049\/jimmunol.2200270","journal-title":"J Immunol"},{"key":"4069_CR310","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev-physiol-022516-034356","volume":"79","author":"KM Vannella","year":"2017","unstructured":"Vannella KM, Wynn TA (2017) Mechanisms of organ injury and repair by macrophages. Annu Rev Physiol 79:593\u2013617. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034356","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"4069_CR311","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","volume":"11","author":"KT Vel\u00e1zquez","year":"2019","unstructured":"Vel\u00e1zquez KT, Enos RT, Bader JE, Sougiannis AT, Carson MS, Chatzistamou I, Murphy EA (2019) Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World J Hepatol 11(8):619. https:\/\/doi.org\/10.4254\/wjh.v11.i8.619","journal-title":"World J Hepatol"},{"issue":"1","key":"4069_CR312","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12866-024-02088-9","volume":"24","author":"E Vico-Oton","year":"2024","unstructured":"Vico-Oton E, Volet C, Jacquemin N, Dong Y, Hapfelmeier S, Meibom KL, Bernier-Latmani R (2024) Strain-dependent induction of primary bile acid 7-dehydroxylation by cholic acid. BMC Microbiol 24(1):286. https:\/\/doi.org\/10.1186\/s12866-024-02088-9","journal-title":"BMC Microbiol"},{"issue":"6","key":"4069_CR313","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","volume":"147","author":"S Wan","year":"2014","unstructured":"Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Welling TH (2014) Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology 147(6):1393\u20131404. https:\/\/doi.org\/10.1053\/j.gastro.2014.08.039","journal-title":"Gastroenterology"},{"issue":"2","key":"4069_CR314","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.gastro.2009.04.062","volume":"137","author":"J Wang","year":"2009","unstructured":"Wang J, Leclercq I, Brymora JM, Xu N, Ramezani-Moghadam M, London RM, George J (2009) Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 137(2):713\u2013723. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.062","journal-title":"Gastroenterology"},{"issue":"1","key":"4069_CR315","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21623945.2021.1967710","volume":"10","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang Y, Xu D (2021a) The roles of T cells in obese adipose tissue inflammation. Adipocyte 10(1):435\u2013445. https:\/\/doi.org\/10.1080\/21623945.2021.1967710","journal-title":"Adipocyte"},{"issue":"1","key":"4069_CR316","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/biomedicines10010084","volume":"10","author":"L Wang","year":"2021","unstructured":"Wang L, Jiao T, Yu Q, Wang J, Wang L, Wang G, Chen W (2021b) Bifidobacterium bifidum shows more diversified ways of relieving non-alcoholic fatty liver compared with Bifidobacterium adolescentis. Biomedicines 10(1):84. https:\/\/doi.org\/10.3390\/biomedicines10010084","journal-title":"Biomedicines"},{"issue":"11","key":"4069_CR317","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/antiox11112287","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Z, Li B, He B, Li L, Nice EC, Xu J (2022) New insights into the gut microbiota in neurodegenerative diseases from the perspective of redox homeostasis. Antioxidants 11(11):2287. https:\/\/doi.org\/10.3390\/antiox11112287","journal-title":"Antioxidants"},{"key":"4069_CR318","doi-asserted-by":"publisher","first-page":"106925","DOI":"10.1016\/j.phrs.2023.106925","volume":"196","author":"L Wang","year":"2023","unstructured":"Wang L, Yan Y, Wu L, Peng J (2023) Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development. Pharmacol Res 196:106925. https:\/\/doi.org\/10.1016\/j.phrs.2023.106925","journal-title":"Pharmacol Res"},{"issue":"4","key":"4069_CR319","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","volume":"50","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Hashimoto E, Ikejima K, Uto H, Ono M, Sumida Y, Shimosegawa T (2015) Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. J Gastroenterol 50(4):364\u2013377. https:\/\/doi.org\/10.1007\/s00535-015-1050-7","journal-title":"J Gastroenterol"},{"key":"4069_CR320","doi-asserted-by":"publisher","first-page":"446765","DOI":"10.1101\/446765","volume":"65","author":"X Wei","year":"2018","unstructured":"Wei X, Zhao X, Chen C, Lu J, Cheng W, Li B, Yuan J (2018a) Klebsiella pneumoniae, one of potential chief culprits of non-alcoholic fatty liver disease: through generation of endogenous ethanol. bioRxiv 65:446765. https:\/\/doi.org\/10.1101\/446765","journal-title":"bioRxiv"},{"key":"4069_CR321","doi-asserted-by":"publisher","unstructured":"Wei X, Zhao X, Chen C, Lu J, Cheng W, Li B, Yuan J (2018b) Klebsiella pneumonia, one of potential chief culprits of non-alcoholic fatty liver disease: through generation of endogenous ethanol. bioRxiv, 446765. https:\/\/doi.org\/10.1101\/446765","DOI":"10.1101\/446765"},{"issue":"2","key":"4069_CR322","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/13543784.2020.1704720","volume":"29","author":"MJ Westerouen Van Meeteren","year":"2020","unstructured":"Westerouen Van Meeteren MJ, Drenth JP, Tjwa ET (2020) Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH). Expert Opin Investig Drugs 29(2):117\u2013123. https:\/\/doi.org\/10.1080\/13543784.2020.1704720","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"4069_CR323","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","volume":"22","author":"M Wlodarska","year":"2017","unstructured":"Wlodarska M, Luo C, Kolde R, d\u2019Hennezel E, Annand JW, Heim CE, Xavier RJ (2017) Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation. Cell Host Microbe 22(1):25\u201337. https:\/\/doi.org\/10.1016\/j.chom.2017.06.007","journal-title":"Cell Host Microbe"},{"issue":"6","key":"4069_CR324","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.00","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Mathis D (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32(6):815\u2013827. https:\/\/doi.org\/10.1016\/j.immuni.2010.06.00","journal-title":"Immunity"},{"issue":"1","key":"4069_CR325","doi-asserted-by":"publisher","first-page":"2302065","DOI":"10.1080\/19490976.2023.2302065","volume":"16","author":"L Wu","year":"2024","unstructured":"Wu L, Zhou J, Zhou A, Lei Y, Tang L, Hu S, Wang S, Xiao X, Chen Q, Tu D, Lu C, Lai Y, Li Y, Zhang X, Tang B, Yang S (2024) Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion. Gut Microbes 16(1):2302065. https:\/\/doi.org\/10.1080\/19490976.2023.2302065","journal-title":"Gut Microbes"},{"key":"4069_CR326","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.812610","volume":"13","author":"H Xiang","year":"2022","unstructured":"Xiang H, Sun D, Liu X, She ZG, Chen Y (2022) The role of the intestinal microbiota in nonalcoholic steatohepatitis. Front Endocrinol 13:812610. https:\/\/doi.org\/10.3389\/fendo.2022.812610","journal-title":"Front Endocrinol"},{"key":"4069_CR327","doi-asserted-by":"publisher","first-page":"1484598","DOI":"10.1155\/2019\/1484598","volume":"2019","author":"MW Xiao","year":"2019","unstructured":"Xiao MW, Lin SX, Shen ZH, Luo WW, Wang XY (2019) Systematic review with meta-analysis: the effects of probiotics in nonalcoholic fatty liver disease. Gastroenterol Ress Pract 2019:1484598. https:\/\/doi.org\/10.1155\/2019\/1484598","journal-title":"Gastroenterol Ress Pract"},{"issue":"4","key":"4069_CR328","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0033-1358523","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, So JS, Park JG, Lee AH (2013) Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis 33(4):301\u2013311. https:\/\/doi.org\/10.1055\/s-0033-1358523","journal-title":"Semin Liver Dis"},{"issue":"1","key":"4069_CR329","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, Yang J (2022) Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct Target Ther 7(1):287. https:\/\/doi.org\/10.1038\/s41392-022-01119-3","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4069_CR330","doi-asserted-by":"publisher","first-page":"2302065","DOI":"10.1080\/19490976.2023.2302065","volume":"16","author":"J Xu","year":"2024","unstructured":"Xu J, Xia Q, Wu T, Shao Y, Wang Y, Jin N, Lu X (2024) Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet. Gut Microbes 16(1):2302065. https:\/\/doi.org\/10.1080\/19490976.2023.2302065","journal-title":"Gut Microbes"},{"issue":"1","key":"4069_CR331","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4161\/gmic.19142","volume":"3","author":"F Yan","year":"2012","unstructured":"Yan F, Polk DB (2012) Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes 3(1):25\u201328. https:\/\/doi.org\/10.4161\/gmic.19142","journal-title":"Gut Microbes"},{"key":"4069_CR332","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00432-006-0184-7","volume":"133","author":"Y Yang","year":"2007","unstructured":"Yang Y, Xiu F, Cai Z, Wang J, Wang Q, Fu Y, Cao X (2007) Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Cancer Res Clin Oncol 133:389\u2013399. https:\/\/doi.org\/10.1007\/s00432-006-0184-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"4069_CR333","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.7150\/ijbs.47177","volume":"16","author":"X Yang","year":"2020","unstructured":"Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X (2020) The gut-liver axis in immune remodeling: new insight into liver diseases. Int J Biol Sci 16(13):2357\u20132366. https:\/\/doi.org\/10.7150\/ijbs.47177","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4069_CR334","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4314\/ajtcam.v11i1.35","volume":"11","author":"Z Yao","year":"2014","unstructured":"Yao Z, Liu XC, Gu YE (2014) Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-induced non-alcoholic steatohepatitis in rats. Afr J Tradit Complement Altern Med 11(1):222\u2013227. https:\/\/doi.org\/10.4314\/ajtcam.v11i1.35","journal-title":"Afr J Tradit Complement Altern Med"},{"issue":"12","key":"4069_CR335","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3760\/cma.j.issn.1007-3418.2017.12.008","volume":"25","author":"F Yao","year":"2017","unstructured":"Yao F, Zheng P, Huang HZ, Bai L, Ding YR, Mei L, Liu SM (2017) Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice. Zhonghua gan zang bing za zhi Zhonghua ganzangbing zazhi Chinese journal of hepatology 25(12):927\u2013933. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2017.12.008","journal-title":"Zhonghua gan zang bing za zhi Zhonghua ganzangbing zazhi Chinese journal of hepatology"},{"key":"4069_CR336","doi-asserted-by":"publisher","first-page":"e37182","DOI":"10.7554\/eLife.37182","volume":"7","author":"L Yao","year":"2018","unstructured":"Yao L, Seaton SC, Ndousse-Fetter S, Adhikari AA, DiBenedetto N, Mina AI, Banks AS, Bry L, Devlin AS (2018) A selective gut bacterial bile salt hydrolase alters host metabolism. Life 7:e37182. https:\/\/doi.org\/10.7554\/eLife.37182","journal-title":"Life"},{"key":"4069_CR337","doi-asserted-by":"publisher","first-page":"e2304567","DOI":"10.1002\/advs.202304567","volume":"12","author":"R Yin","year":"2024","unstructured":"Yin R, Wang T, Sun J, Dai H, Zhang Y, Liu N, Liu H (2024) Postbiotics from Lactobacillus johnsonii activates gut innate immunity to mitigate alcohol-associated liver disease. Adv Sci 12:e2304567. https:\/\/doi.org\/10.1002\/advs.202304567","journal-title":"Adv Sci"},{"key":"4069_CR338","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.fct.2012.10.062","volume":"52","author":"HZ Ying","year":"2013","unstructured":"Ying HZ, Liu YH, Yu B, Wang ZY, Zang JN, Yu CH (2013) Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food Chem Toxicol 52:53\u201360. https:\/\/doi.org\/10.1016\/j.fct.2012.10.062","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"4069_CR339","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s12276-020-00509-4","volume":"52","author":"Y Yoon","year":"2020","unstructured":"Yoon Y, Kim G, Noh MG, Park JH, Jang M, Fang S, Park H (2020) Lactobacillus fermentum promotes adipose tissue oxidative phosphorylation to protect against diet-induced obesity. Exp Mol Med 52(9):1574\u20131586. https:\/\/doi.org\/10.1038\/s12276-020-00509-4","journal-title":"Exp Mol Med"},{"key":"4069_CR340","doi-asserted-by":"publisher","first-page":"1129904","DOI":"10.3389\/fmicb.2023.1129904","volume":"14","author":"SJ Yoon","year":"2023","unstructured":"Yoon SJ, Yu JS, Min BH, Gupta H, Won SM, Park HJ, Suk KT (2023) Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Front Microbiol 14:1129904. https:\/\/doi.org\/10.3389\/fmicb.2023.1129904","journal-title":"Front Microbiol"},{"issue":"1","key":"4069_CR341","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"4069_CR342","doi-asserted-by":"publisher","first-page":"1339207","DOI":"10.3389\/fimmu.2024.1339207","volume":"15","author":"C Yu","year":"2024","unstructured":"Yu C, Xu J, Xu S, Tang L, Han Q, Zeng X, Sun Z (2024) Exploring genetic associations of Crohn\u2019s disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations. Front Immunol 15:1339207. https:\/\/doi.org\/10.3389\/fimmu.2024.1339207","journal-title":"Front Immunol"},{"issue":"4","key":"4069_CR343","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, Liu D (2019) Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 30(4):675\u2013688. https:\/\/doi.org\/10.1016\/j.cmet.2019.08.018","journal-title":"Cell Metab"},{"key":"4069_CR344","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","volume":"37","author":"SH Zeisel","year":"2017","unstructured":"Zeisel SH, Warrier M (2017) Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr 37:157\u2013181. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064732","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"4069_CR345","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/imt2.261","volume":"3","author":"A Zha","year":"2024","unstructured":"Zha A, Qi M, Deng Y, Li H, Wang N, Wang C, Tan BE (2024) Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis. iMeta 3(6):e261. https:\/\/doi.org\/10.1002\/imt2.261","journal-title":"iMeta"},{"issue":"37","key":"4069_CR346","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3748\/wjg.v16.i37.4652","volume":"16","author":"YT Zhan","year":"2010","unstructured":"Zhan YT, An W (2010) Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 16(37):4652\u20134660. https:\/\/doi.org\/10.3748\/wjg.v16.i37.4652","journal-title":"World J Gastroenterol"},{"issue":"17","key":"4069_CR347","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.3390\/ijms23179588","volume":"23","author":"P Zhang","year":"2022","unstructured":"Zhang P (2022) Influence of foods and nutrition on the gut microbiome and implications for intestinal health. Int J Mol Sci 23(17):9588. https:\/\/doi.org\/10.3390\/ijms23179588","journal-title":"Int J Mol Sci"},{"key":"4069_CR348","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-061020-053215","volume":"39","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Cao X (2021) Epigenetic remodeling in innate immunity and inflammation. Annu Rev Immunol 39:279\u2013311. https:\/\/doi.org\/10.1146\/annurev-immunol-061020-053215","journal-title":"Annu Rev Immunol"},{"key":"4069_CR349","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1017\/S0007114520001870","volume":"125","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou H, Zhou X, Sun J, Liang X, Lv Y, Bai L, Zhang J, Gong P, Liu T, Yi H, Wang J, Zhang L (2020) Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. Br J Nutr 125:521\u2013529. https:\/\/doi.org\/10.1017\/S0007114520001870","journal-title":"Br J Nutr"},{"issue":"5","key":"4069_CR350","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/microorganisms9051062","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang C, Franklin CL, Ericsson AC (2021) Consideration of gut microbiome in murine models of diseases. Microorganisms 9(5):1062. https:\/\/doi.org\/10.3390\/microorganisms9051062","journal-title":"Microorganisms"},{"key":"4069_CR351","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.112818","volume":"161","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhao Y, Cui JG, Li XN, Li JL (2022a) DEHP-induced mitophagy and mitochondrial damage in the heart are associated with dysregulated mitochondrial biogenesis. Food Chem Toxicol 161:112818. https:\/\/doi.org\/10.1016\/j.fct.2022.112818","journal-title":"Food Chem Toxicol"},{"key":"4069_CR352","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.945368","volume":"12","author":"YL Zhang","year":"2022","unstructured":"Zhang YL, Li ZJ, Gou HZ, Song XJ, Zhang L (2022b) The gut microbiota\u2013bile acid axis: A potential therapeutic target for liver fibrosis. Front Cell Infect Microbiol 12:945368. https:\/\/doi.org\/10.3389\/fcimb.2022.945368","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"4069_CR353","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.4049\/jimmunol.2200965","volume":"210","author":"W Zhang","year":"2023","unstructured":"Zhang W, Mackay CR, Gershwin ME (2023a) Immunomodulatory effects of microbiota-derived short-chain fatty acids in autoimmune liver diseases. J Immunol 210(11):1629\u20131639. https:\/\/doi.org\/10.4049\/jimmunol.2200965","journal-title":"J Immunol"},{"issue":"1","key":"4069_CR354","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01134-1","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Xu ZX (2023b) Short-chain fatty acids in diseases. Cell Commun Signal 21(1):212. https:\/\/doi.org\/10.1186\/s12964-023-01134-1","journal-title":"Cell Commun Signal"},{"issue":"3","key":"4069_CR355","doi-asserted-by":"publisher","first-page":"e05323","DOI":"10.1128\/spectrum.05323-22","volume":"11","author":"R Zhang","year":"2023","unstructured":"Zhang R, Xu Z, Xue G, Feng J, Du B, Gan L, Yuan J (2023c) Combined methylation and transcriptome analysis of liver injury of nonalcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Microbiol Spectr 11(3):e05323-e5422. https:\/\/doi.org\/10.1128\/spectrum.05323-22","journal-title":"Microbiol Spectr"},{"key":"4069_CR356","doi-asserted-by":"publisher","first-page":"1288856","DOI":"10.3389\/fmicb.2024.1288856","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhou J, He Z, Li H (2024a) Bacteroides and NAFLD: pathophysiology and therapy. Front Microbiol 15:1288856. https:\/\/doi.org\/10.3389\/fmicb.2024.1288856","journal-title":"Front Microbiol"},{"key":"4069_CR357","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1002\/fsn3.3590","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xu J, Dong X, Tang J, Xie Y, Yang J, Zou L, Wu L, Fan J (2024b) Bifidobacterium longum BL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. Food Sci Nutr 12:6442\u20136460. https:\/\/doi.org\/10.1002\/fsn3.3590","journal-title":"Food Sci Nutr"},{"issue":"1","key":"4069_CR358","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-024-00378","volume":"19","author":"L Zhang","year":"2024","unstructured":"Zhang L, Gong X, Tan J, Zhang R, Li M, Liu C, Li X (2024c) Lactobacillus reuteri mitigates hepatic ischemia\/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2\/HO-1 signaling. Biol Direct 19(1):23. https:\/\/doi.org\/10.1186\/s13062-024-00378","journal-title":"Biol Direct"},{"key":"4069_CR359","doi-asserted-by":"publisher","first-page":"2794591","DOI":"10.1155\/2016\/2794591","volume":"2016","author":"X Zhao","year":"2016","unstructured":"Zhao X, Han Q, Liu Y, Sun C, Gang X, Wang G (2016) The relationship between branched-chain amino acid related metabolomic signature and insulin resistance: a systematic review. J Diabetes Res 2016:2794591. https:\/\/doi.org\/10.1155\/2016\/2794591","journal-title":"J Diabetes Res"},{"issue":"20","key":"4069_CR360","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.3748\/wjg.v25.i20.2450","volume":"25","author":"ZH Zhao","year":"2019","unstructured":"Zhao ZH, Xin FZ, Zhou D, Xue YQ, Liu XL, Yang RX, Fan JG (2019) Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. World J Gastroenterol 25(20):2450. https:\/\/doi.org\/10.3748\/wjg.v25.i20.2450","journal-title":"World J Gastroenterol"},{"issue":"7800","key":"4069_CR361","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","volume":"579","author":"S Zhao","year":"2020","unstructured":"Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, Wellen KE (2020) Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature 579(7800):586\u2013591. https:\/\/doi.org\/10.1038\/s41586-020-2101-7","journal-title":"Nature"},{"key":"4069_CR362","doi-asserted-by":"publisher","first-page":"1207132","DOI":"10.3389\/fmicb.2023.1207132","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, Yang CE, Liu T, Zhang MX, Niu Y, Wang M, Yu J (2023a) The roles of gut microbiota and its metabolites in diabetic nephropathy. Front Microbiol 14:1207132. https:\/\/doi.org\/10.3389\/fmicb.2023.1207132","journal-title":"Front Microbiol"},{"issue":"11","key":"4069_CR363","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e12820","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhao F, Yuan J, Liu H, Wang Y (2023b) Gut microbiota metabolites, redox status, and the related regulatory effects of probiotics. Heliyon 9(11):e12820. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e12820","journal-title":"Heliyon"},{"issue":"7","key":"4069_CR364","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037271","volume":"103","author":"J Zhao","year":"2024","unstructured":"Zhao J, Li B, Zhang K, Zhu Z (2024) The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials. Medicine 103(7):e37271. https:\/\/doi.org\/10.1097\/MD.0000000000037271","journal-title":"Medicine"},{"issue":"17","key":"4069_CR365","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3748\/wjg.v25.i17.1917","volume":"25","author":"D Zhou","year":"2019","unstructured":"Zhou D, Fan JG (2019) Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol 25(17):1917\u20131928. https:\/\/doi.org\/10.3748\/wjg.v25.i17.1917","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4069_CR366","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/pr.2014.160","volume":"77","author":"L Zhu","year":"2015","unstructured":"Zhu L, Baker RD, Baker SS (2015) Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 77(1):245\u2013251. https:\/\/doi.org\/10.1038\/pr.2014.160","journal-title":"Pediatr Res"},{"key":"4069_CR367","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Ling Z (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555. https:\/\/doi.org\/10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"},{"issue":"23","key":"4069_CR368","doi-asserted-by":"publisher","first-page":"16733","DOI":"10.3390\/ijms242316733","volume":"24","author":"X Zhu","year":"2023","unstructured":"Zhu X, Cai J, Wang Y, Liu X, Chen X, Wang H, Wu S (2023) A high-fat diet increases the characteristics of gut microbial composition and the intestinal damage associated with non-alcoholic fatty liver disease. Int J Mol Sci 24(23):16733. https:\/\/doi.org\/10.3390\/ijms242316733","journal-title":"Int J Mol Sci"},{"key":"4069_CR369","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0642-6","volume":"14","author":"G Zilberman-Schapira","year":"2016","unstructured":"Zilberman-Schapira G, Zmora N, Itav S, Bashiardes S, Elinav H, Elinav E (2016) The gut microbiome in human immunodeficiency virus infection. BMC Med 14:1\u201311. https:\/\/doi.org\/10.1186\/s12916-016-0642-6","journal-title":"BMC Med"},{"key":"4069_CR370","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fphys.2012.00056","volume":"3","author":"HW Zimmermann","year":"2012","unstructured":"Zimmermann HW, Trautwein C, Tacke F (2012) Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 3:56. https:\/\/doi.org\/10.3389\/fphys.2012.00056","journal-title":"Front Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04069-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:36:59Z","timestamp":1758256619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04069-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":370,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4069"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04069-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the manuscript work was conducted in the absence of any commercial relationship that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}